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CHAPTER 1: GENERAL INTRODUCTION 
DISSERTATION ORGANIZATION 
This dissertation follows the 'new' format, in which manuscripts accepted, 
submitted, or intended to be submitted are utilized as chapters. Each manuscript 
chapter begins with the title of the work, the list of authors, and the contribution of 
those authors to the work. 
The dissertation begins with an abstract, which briefly outlines the purpose 
and major findings of the completed work. Following the current section, which 
outlines the organization of this document, is the literature review. The literature 
review contains information intended to acquaint the reader with background 
information relevant to the other chapters of the dissertation. Although extensive, 
the literature review does not discuss all research previously completed on the 
particular topic. Instead, key points and findings are discussed at a level to bring 
clear understanding to that particular topic. 
Additional data generated, but not contained in a manuscript and, therefore, 
not included in a chapter, is included in the appendix. 
LITERATURE REVIEW 
Antiviral Immunity 
Recognition and activation 
The innate antiviral immune response does not require antigen memory and 
is instead activated by recognition of conserved viral epitopes, such as double-
stranded RNA (dsRNA). During replication of the viral genome inside the host cell, 
dsRNA intermediates can be recognized by various host cell proteins, such as toll­
like receptor (TLR) 3 and double-stranded RNA dependent protein kinase R (PKR). 
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Once dsRNA binds to either TLR3 or PKR, differential signaling pathways are 
activated by a series of phosphorylation events, leading to the transcription of 
proinflammatory cytokines and type I interferons [such as interferon-beta (IFN-(3) and 
interferon-alpha (IFN-a)]. 
TLR3, like TLR4, is unique from other TLRs in having the ability to signal via 
both the myeloid differentiation factor 88 (MyD88)-dependent pathway and MyD88-
independent pathways (Basu & Fenton, 2004) (figure 1). The IL-1 receptor (IL-1R) 
and TLR protein family share downstream signaling proteins, including MyD88, IL-
1R associated protein kinase (IRAK), and tumor necrosis factor receptor associated 
factor 6 (TRAF6). The shared signaling molecules bind a common domain on the 
receptor referred to as the toll/IL-1 R homology domain (TIR) (Basu & Fenton, 2004). 
The transcription of proinflammatory cytokines, such as TNF-a, IL-1 (3, IL-6, and IL-8, 
has been shown to be induced via the MyD88-dependent signaling pathway (Akira & 
Hoshino, 2003). Upon dsRNA binding to TLR3 there is activation of NFKB and MAP 
kinases via MyD88-IRAK-TRAF6 (Matsumoto et al., 2004). Transduction of the 
TLR3 signal via the MyD88-independent signaling pathway is propagated by TRI F 
(toll/IL-1 R domain-containing, adapter inducing IFN-(3 protein; also referred to as 
TICAM-1), which activates interferon-regulatory factor 3 (IRF-3) and results in the 
subsequent transcription of IFN-p and RANTES (Akira & Hoshino, 2003, Oshiumi et 
al., 2003). 
It has recently been shown that TLR3 induced IFN-(3 transcription initiated by 
the NFKB or MAP kinase pathway can occur independently of the TIR domain, a 
constituent of both the MyD88-dependent and independent pathways (figure 2). 
Instead of utilizing a TIR-associated signaling pathway, dsRNA binding toTLR3 
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directly activates TRAF6, and TRAF6 subsequently initiates PKR activation (Jiang et 
al., 2003). PKR can, in turn, induce the transcription of IFN-(B. Additional details on 
the role of PKR in the type I interferon response are described in further detail 
below. Overall, these studies indicated that there are multiple signaling pathways in 
which TLR3 can converge and signaling is likely differentially regulated between cell 
types. 
IFN-(3 and IFN-a have potent antiviral activities, and can work in an 
autocrine/paracrine manner to activate infected cells or 'alert' nearby cells to a 
potential threat (figure 2). IFN-(B and IFN-a utilize a common receptor called the type 
I interferon receptor (IFN-R), which is composed of two subunits - IFNAR1 and 
IFNAR2. After ligand binding, a receptor rearrangement and dimerization occurs that 
results in the autophosphorylation and activation ofJak (Janus activated kinase). 
The signal is transduced by the phosphorylation of STAT (signal transducer and 
activator of transcription) proteins (Platanias, 2005). A heterodimer consisting of 
phosphorylated STAT-1 and STAT-2 translocates into the nucleus and binds to IRF-
9 (p48). This heterotrimer complex, referred to as ISGF3, binds to DNA at the 
interferon stimulated response element (ISRE), which is a conserved sequence in 
the promoter region of several genes (Taniguchi &Takaoka, 2002). Consequently, 
IFN-a/p signals for the transcription of several major antiviral effectors, including Mx, 
PKR, and 2'-5' oligoadenylate synthetase (Asano et al., 2002, Asa no et al., 2004, 
Muller et al., 1992). In addition, type I interferon has been shown to induce an 
upregulation in the expression of major histocompatability complex (MHC) class I. 
MHC class I is involved in antigen presentation to CD8 T-cells. 
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Mx proteins are a family of GTPases that are thought to interfere with viral 
replication and assembly (Kochs et al., 2005). It has been shown that Mx protein 
interacts with viral ribonucleoprotein complexes and prevents their transport into the 
nucleus (Haller & Kochs, 2002). In addition, Mx in the nucleus of host cells was 
shown to inhibit viral polymerase activity (Pavlovic et al., 1993). Porcine Mx protein 
is upregulated in response to recombinant IFN-a, synthetic dsRNA 
(polyinosinic:polycytidylic acid, polylC), vesicular stomatitis virus, and influenza virus 
(Horisberger, 1992, Muller et al., 1992), indicating a role for Mx in the innate antiviral 
immune response. 
PKR is a serine/threonine kinase constitutive^ expressed in the cytoplasm of 
the host cell, but can also be upregulated in an interferon-dependent manner. PKR 
is involved in activating the type I interferon response in addition to functioning as an 
antiviral mediator (Der & Lau, 1995). Upon binding to dsRNA, an intermediate of 
viral replication, PKR is autophosphorylated. Phosphorylated PKR is able to hinder 
viral mRNA translation by phosphorylating the alpha subunit of the eukaryotic 
initiation factor 2 (elF-2a), which renders it incapable of initiating protein synthesis. In 
addition, PKR activates a member of the NFKB transcription factor family via 
activation of IKB kinase, which triggers type I interferon production (Chu et al., 1999, 
Kumar et al., 1994). Therefore, PKR is not only involved in the response to type I 
interferon, but can induce the production of type I interferon as well (Balachandran et 
al., 2000, Bonnet et al., 2000, Der & Lau, 1995). Deciphering the role of PKR in the 
host immune response has been accomplished by using the chemical compound, 2-
aminopurine (2-AP). 2-AP specifically targets serine/threonine kinases and has been 
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shown to specifically inhibit PKR function (Chesler et al., 2003, Hu & Conway, 1993, 
Rowland et al., 2001, Silva et al., 2004). 
Toll-like receptors are type I transmembrane proteins with an extracellular 
domain involved in ligand recognition, a transmembrane domain, and a cytoplasmic 
domain involved in transducing signals. It was initially assumed that all TLRs would 
be expressed on the cell surface, but further investigation revealed that some TLRs, 
including TLR3, are expressed only in intracellular compartments, or endosomes 
(Matsumoto et al., 2003, Nishiya & DeFranco, 2004). It has recently been shown that 
TLR3 is colocalized to an intracellular compartment with TLR7, which recognizes 
single-stranded RNA. The intracellular compartment containing TLR3 and TLR7 was 
located adjacent to phagosomes containing apoptotic particles (Nishiya et al., 2005). 
It is thought that TLR3 and TLR7 come into contact with their respective ligand after 
DCs or MOs phagocytize virus-infected apoptotic or necrotic cells. The mechanism 
in which synthetic dsRNA (polylC) reaches TLR3 is unknown, but it is possible that 
DCs or MOs may take up the molecule and it is subsequently trafficked to 
endosomal compartments expressing TLR3. In addition, polylC or viral RNA taken 
up by a M<t> or DC may be released into the cell cytoplasm, where it could interact 
with PKR. Further studies are needed to elucidate the mechanism in which viral 
RNA and polylC are recognized by the host PRRs, TLR3 and PKR. 
Dendritic cells and macrophages 
Antigen-presenting cells (APC), such as dendritic cells (DC) and 
macrophages (MO), play a key role in immune regulation by linking the innate and 
adaptive immune response. DCs are professional antigen presenting cells 
responsible for capturing and presenting antigen for the activation of naïve T-cells. 
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DCs reside in various tissues, continuously capturing antigen. Upon immune and 
inflammatory stimulation, immature dendritic cells become activated and migrate to 
lymphoid organs, where the focus shifts from antigen capture to antigen processing 
and presentation. During this time, dendritic cells mature and may upregulate co-
stimulatory molecules, such as CD80 and/or CD86. Once in the lymph node, T-cells 
sample antigen presented in the context of the major histocompatibility complex 
(MHC) on the DC. Upon recognition of cognate antigen, the T-cell receives 
secondary activation signals via co-stimulatory molecules. In addition, DCs produce 
soluble factors, cytokines such as IL-10 or IL-12, that affect T-cell activation and 
response. Overall, a series of interactions between the activated DC and naïve T-
cells triggers T-cell proliferation, activation, and subsequent response. 
Macrophages (MOs) also serve as APCs, but have a more specialized 
function as phagocytes. M0s express and upregulate MHC molecules in response 
to antigenic or inflammatory stimuli, as DCs do, but have been shown not to 
upregulate the expression of costimulatory molecules (CD80/86) as efficiently as 
DCs. Consequently, the activation signal delivered to naïve T-cells from M<t>s may 
not be as strong as the signal delivered by a DC. However, M0s have recently been 
described to be as efficient at activating CD8+ T-cells as DCs (Pozzi et al., 2005). 
Porcine DC populations circulating in the blood include myeloid DCs (mDC) 
and plasmacytoid dendritic cells (pDC), or natural interferon producing cells. 
Porcine peripheral blood mDCs are CD172a+(SWC3) CD4" CD14" and specialize in 
T-cell stimulation whereas blood pDCs are CD172a+ CD4+ CD14" and produce 
interferon-alpha (IFN-a) in response to viral stimulation (Summerfield et al., 2003). 
Monocyte-derived dendritic cells (MDDC) are derived from peripheral blood 
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monocytes using recombinant granulocyte-macrophage colony-stimulating factor 
(GM-CSF) and recombinant interleukin-4 (IL-4) (Kiertscher & Roth, 1996, Paillot et 
al., 2001). MDDCs express CD11c, CD1, CD172a, and CD16, but are CD14" 
(Paillot et al., 2001). In addition, MDDCs express MHC class I, MHC class II, and 
low levels of CD80/86. 
Along with phenotype, APCs are often assessed on functional abilities, such 
as antigen uptake and the induction naïve T-cell proliferation. DCs are distinguished 
as APCs by the specialized uptake of small molecules via defined pathways, such 
as receptor mediated endocytosis and macropinocytosis. Antigen uptake function 
can be evaluated using tracer endocytosis assays that monitor the uptake of labeled 
antigen, such as fluorescently labeled dextran or ovalbumin, by the cell under 
investigation. The induction of naïve T-cell proliferation is often assessed using a 
mixed leukocyte reaction. The APC of interest is evaluated on the ability to stimulate 
T-cell proliferation in an allogeneic response. In this case, allogeneic T-cells are 
incubated with APCs at various stimulator to responder (APC to T-cell) ratios for a 
determined amount of time, such as five days, and then T-cell proliferation is 
assessed. T-cells may be fluorescently labeled prior to mixing with APCs and 
proliferation subsequently analyzed using flow cytometry. As the parent population 
proliferates, the fluorescent dye is distributed equally to daughter cells and 
fluorescence decreases. Overall, a combination of phenotypic and functional 
analysis is used to identify a cell as an APC, whether it is a DC or M<t>. 
The majority of studies investigating DC function and subsequent changes 
induced by a particular pathogen are carried out using either monocyte-derived 
dendritic cells (MDDC) or bone-marrow derived dendritic cells (BMDC). This is also 
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true for MOs, in which monocytes or bone marrow is used to derive MOs in culture. 
In addition, murine MO cell lines are often used to investigate MO function. Although 
these studies are very valuable and have provided useful data, the information 
gleaned from these studies may not correlate to tissue-specific DCs or MOs residing 
in particular anatomical locations. Therefore, it becomes critical to compare results 
from culture-derived cells to cells isolated from anatomical regions pertinent to a 
particular infection; for example, investigating the response of lung DCs or alveolar 
MOs to respiratory pathogens. The information obtained from such studies will be 
relevant to the natural biological system, not just a particular derived cell type. 
Type I interferon and adaptive immunity 
DCs play a role in antiviral immunity by providing early innate protection against viral 
replication and by presenting antigen to T-cells for initiation of the adaptive immune 
response. Type I interferon (IFN-a/p) is critical for innate control of virus replication 
as well as activation of the adaptive immune response (Bonjardim, 2005). DC 
maturation for enhanced antigen-presentation is important for activating adaptive 
immunity. Type I interferon is required for DC maturation in response to dsRNA or 
viral infection (Honda et al., 2005). In addition, IFN-a/p provides DC with protection 
to viral cytopathic effects, allowing for continued antigen-presentation by DC (Cella 
et al., 1999). 
Pathogen recognition by innate immune receptors induces the secretion of 
cytokines which promote development of Th1 immune responses. While it is 
accepted that IL-12 plays a critical role in Th1 development, the role for type I 
interferons has been controversial. For example, IFN-a has been shown to enhance 
the production of IFN-y from human CD4+ T-cells, whilst decreasing production of 
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the Th2 inducing cytokine, IL-4 (Brinkmann et al., 1993). Conversely, IFN-a does not 
drive Th1 development of murine CD4+ T-cells (Rogge et al., 1998). Taken together, 
these data indicate a species specific role for IFN-a in promoting development of 
Th1 responses. To date, studies investigating the activation of porcine CD4+ T-cells 
by porcine type I interferons have not been described. 
Type I interferons can also direct the activation of Mcp to induce a Th1 
adaptive response. IFN-a pretreated Mcp subsequently stimulated with either TLR3 
or TLR4 ligands released cytokines capable of inducing the expression of IFN-y in 
NK cells, suggesting that IFN-a contributes to TLR-induced development of the Th1 
immune response. Without IFN-a pretreatment, soluble factors produced by Mcp do 
not induce IFN-y production by NK cells (Siren et al., 2004). 
PRRSV Pathogenesis 
Identification of PRRSV 
'Mystery swine disease' was first described in the late 1980s, and the 
causative agent, porcine reproductive and respiratory syndrome (PRRS) virus, was 
first described as Lelystad virus in the Netherlands in 1991 (Wensvoort et al., 1991) 
and subsequently isolated in the United States in 1992 (Collins, 1992). The virus is a 
single-stranded, positive-sense RNA virus belonging to the Arteriviridae family 
(Meulenberg et al., 1993). Viruses of the Arteriviridae family primarily infect cells of 
the monocyte/macrophage lineage and cause a persistent infection in their 
respective host (Plagemann, 1992). PRRS virus infection in pregnant sows or gilts 
can cause abortion and/or the death of weak-born piglets. In addition, it can cause 
respiratory distress in pigs of all ages (Albina, 1997). 
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The pathogenesis of PRRSV consists of an acute stage, characterized by 
viremia lasting approximately four weeks, followed by a chronic stage in which 
viremia has resolved, but viable virus can be isolated from various tissues. The 
chronic stage of disease can last anywhere from three to six months (Murtaugh et 
al., 2002, Wills et al., 1997) and during this time PRRSV can be isolated from tonsil, 
lymph nodes, and semen (Christopher-Hennings et al., 1995, Duan et al., 1997b). 
Although the mechanism for PRRSV persistence is unknown, it is suggested that 
PRRSV does not enter latency, but instead there is continuous viral replication 
(Allende et al., 2000). 
Cell susceptiblity 
PRRSV primarily infects lung MOs, including alveolar and intravascular MOs 
(Duan et al., 1998, Thanawongnuwech et al., 2000), and enters permissive cells via 
receptor-mediated endocytosis (Nauwynck et al., 1999). Peripheral blood monocytes 
have been shown to become permissive to PRRSV after overnight culture and 
monocyte-derived MOs support viral replication (Duan et al., 1997a). Heparin 
sulfate and sialoadhesin have been identified as receptors for PRRSV (Duan et al., 
1998). It is thought that tissue MOs also support viral replication, as cells resembling 
MOs or DCs in the tonsil and lymph nodes are positive for viral antigen after in vivo 
infection (Christopher-Hennings et al., 2001, Duan et al., 1997b, Halbur et al., 1995). 
PRRSV initially binds to heparin sulfate moieties on the cell surface and this 
event enhances the interaction between virus and cell-associated sialoadhesin, 
which is required for viral internalization (Delputte & Nauwynck, 2004, Vanderheijden 
et al., 2003). Although internalization is mediated by sialoadhesin, its expression 
alone is not enough for cells to be productively infected, as viral genome is not 
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released into the cytoplasm of cells engineered to express recombinant sialoadhesin 
(Vanderheijden et al., 2003). Other host factors involved in PRRSV permissiveness 
remain to be determined. PRRSV replication occurs in the cytoplasm and virion 
formation occurs in vesicles associated with the endoplasmic reticulum and Golgi 
apparatus. 
Vaccination 
To date, PRRS is one of the most important diseases of swine worldwide, 
inducing disease in pigs of all ages. Currently, there is an inactivated (killed) and 
modified-live (attenuated) vaccine available; however, efficacy of the killed vaccine is 
questionable and the attenuated-virus has been known to revert to virulent form of 
the virus (Opriessnig et al., 2002, Mengeling et al., 2003, Nielsen et al., 2001, 
Mavromatis et al., 1999, Bouwkamp, 1999, Christopher-Hennings et al., 1997 and 
Plana-Duran et al., 1997). Consequently, either a new, effective and safe vaccine 
needs to be developed or a mechanism for enhancing the protection provided by 
currently available vaccines is urgently needed. 
One challenge in PRRSV vaccine development is the genotypic differences 
between PRRSV isolates. Vaccination, or exposure, can be protective against 
challenge with a homologous strain of virus; however, vaccination or previous 
exposure, does not protect an animal when challenged with a heterologous strain of 
PRRSV (Labarque et al., 2003, Mengeling et al., 1998, Lager et al., 1999). Use of a 
multivalent vaccine has been proposed to overcome isolate variances; however, the 
safety of a multi-strain vaccine approach requires further study (Mengeling et al., 
2003). 
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Recent efforts have focused on utilizing an adjuvant to enhance the immune 
response generated with PRRSV vaccination. Foss et al. showed that IL-12 or 
cholera toxin can enhance immune responses to the live-attenuated PRRSV vaccine 
by enhancing IFN-y production by T-cells after challenge or enhancing antibody 
production in response to vaccination (Foss et al., 2002). A plasmid encoding IFN-a 
given in combination to modified-live vaccine enhanced primary virus-specific IFN-y 
response, but did not alter the production of anti-virus antibody (Meier et al., 2004). 
A recent study utilized PRRSV ORF5 peptide using IL-12 as an adjuvant with 
Ingelvac® PRRS MLV and reported enhanced cell-mediated immune responses 
compared to MLV alone (Charerntantanakul et al., 2006). Taken together, these 
studies indicate utilizing adjuvant(s) with PRRSV vaccination may enhance immune 
responsiveness to vaccination, as well as protection upon viral challenge. 
Immune Response to PRRSV 
Immunomodulation 
When PRRSV first emerged, it was often isolated from pigs along with other 
viral and/or bacterial pathogens. This observation led to the theory that 
immunomodulation by PRRSV infection resulted in immunosuppression, leaving an 
animal susceptible to other microbial infections. A mechanism in which PRRSV 
causes immunomodulation has not been identified; however, it has been shown that 
PRRSV is cytotoxic to alveolar MOs in vitro. Uninfected cells in vitro exhibit normal 
phagocytic function, indicating that PRRSV does not inhibit phagocytosis by inducing 
the release of a soluble suppressive factor (Oleksiewicz & Nielsen, 1999). However, 
due to the cytolytic nature of PRRSV (Miller & Fox, 2004), a decrease in the number 
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of pulmonary phagocytic cells may explain why pigs become susceptible to 
secondary infections during PRRSV infection. 
The number of PRRSV susceptible cells in the lung may play a role in the 
severity of disease during infection. Younger pigs have a higher percentage of 
PRRSV susceptible cells (Shibata et al., 1997) and consequently, may be more 
susceptible to PRRSV infection. In addition, young piglets may be more susceptible 
to secondary infections due to the loss of phagocytic cells (MOs) during PRRSV 
infection, which play a key role in microbial clearance and surveillance (Choi et al., 
2002, Drew, 2000). In contrast, one study shows that PRRSV infection does not 
cause a decrease in the number of mononuclear cells in the lung lumen (Samsom et 
al., 2000). Thus, further studies are required to fully elucidate the involvement of 
PRRSV suspectible MOs on PRRSV pathogenesis as well as the role of these cells 
during infection with multiple pathogens. 
Clinical disease is often exacerbated when animals are concurrently infected 
with PRRSV and another organism, such as Bordetella bronchiseptica (Brockmeier 
et al., 2000) or Mycoplasma hyopneumoniae (Thanawongnuwech et al., 2004). 
Dual-infected animals may exhibit pyrexia, anorexia, and the severity and duration of 
pneumonia will be longer than animals infected with only a single agent. It has been 
shown that proinflammatory cytokine levels are elevated when PRRSV and another 
respiratory pathogen is present (Thanawongnuwech et al., 2004, 
Thanawongnuwech et al., 2001), which may cause enhanced clinical signs and 
more severe pneumonia. However, some research groups have concluded that 
PRRSV does not make an animal susceptible to secondary infections (Albina et al., 
1998) or inhibit the immune response to a different microbe, such as pseudorabies 
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virus (De Bruin et al., 2000). Overall, there is conflicting data on immunomodulation 
directly resulting from PRRSV infection. There are several variables, such as animal 
age and virus strain used during a study, that could result in different findings 
amongst research groups. As more tools and techniques become available to study 
the porcine immune response, discerning the immunomodulatory abilities of PRRSV 
may become clearer. 
Humoral immunity 
There are several pieces of evidence indicating an aberrant activation of the 
humoral immune response during PRRSV infection. First, although there is a 
detectable increase in serum antibody early after PRRSV infection, virus specific 
antibodies have minimal ability in neutralizing viral infectivity (Gonin et al., 1999, 
Loemba et al., 1996). In addition, the non-neutralizing antibody produced in 
response to PRRSV has been shown to facilitate viral uptake into M<t>s via antibody 
dependent enhancement (Yoon et al., 1996). Antibody titers, measured by enzyme-
linked immunosorbent assay (ELISA), peak at approximately the same time 
neutralizing antibody is detected, and coincides with viral clearance from the lung 
(Labarque et al., 2000). However, the production of neutralizing antibody is variable 
amongst animals and wanes over time (Meier et al., 2003). 
In addition to the lack of neutralizing antibody production, it has been shown 
that there is polyclonal B-cell activation during PRRSV infection, and antibody 
produced can be directed at host tissue (Lamontagne et al., 2001, Lemke et al., 
2004). The early production of non-neutralizing antibody is likely due to the 
polyclonal expansion and activation of B-cells. However, it is possible that PRRSV is 
able to direct antibody production to immunodominant non-neutralizing epitopes of 
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the virus (Meier et al., 2003, Ostrowski et al., 2002), delaying the production of 
neutralizing antibody. However, even the eventual production of neutralizing 
antibody in PRRSV infected pigs is not sufficient to completely effect the clearance 
of virus from lymphoid tissue. This lends support to the hypothesis that there is a 
reliance on the cell mediated immune response for clearance of PRRSV (Meier et 
al., 2003). 
Cell mediated immunity 
The cell mediated immune response is often evaluated by the production of 
IFN-y in response to a particular pathogen. Other measurements, such as T-cell 
proliferation to antigen, are used as well. Several research groups have described 
the PRRSV-induced IFN-y response as a gradually developing response, taking 
months to plateau (Batista et al., 2004, Meier et al., 2003, Piras et al., 2005). 
PRRSV replication is sensitive to the effects of IFN-y, as alveolar MOs pretreated in 
vitro with IFN-y affected the ability of to replicate in these cells (Bautista & Molitor, 
1997, Rowland et al., 2001). 
The kinetics of T-cell proliferation in response to PRRSV is similar to that of 
IFN-y production, with expansion first measured at four weeks post-infection, and 
peaking at seven weeks. The majority of IFN-y is produced by CD8+ T-cells while 
mainly CD4+ T-cells proliferate in response to PRRSV (Bautista & Molitor, 1997). 
There is an influx of CD8+ T-cells into the bronchial-alveolar space during PRRSV 
infection, increasing until about 3 weeks post-infection. The infiltrating CD8+ T-cells 
are both cytolytic T-cells (CD2+ yô"CD8+CD6+) and natural killer cells (CD2+ y<5" 
CD8+CD6") (Samsom et al., 2000), which could serve as sources of IFN-y during 
PRRSV infection. In addition to T lymphocytes, alveolar MOs themselves may 
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produce IFN-y during PRRSV infection, as they are shown to be IFN-y+ using 
immunohistological staining of lung sections (Thanawongnuwech et al., 2003). 
A recent paper reports that the levels of PRRSV specific T-cells and MOs 
recruited to PRRSV-positive tissues is independent of viral load (Xiao et al., 2004). 
Although the virus subverts the host immune defenses for a period of time, there is 
an eventual clearance of the virus from the animal. Therefore, an effective immune 
response does develop overtime. This study shows that the number of MOs and T-
cells in secondary lymphoid tissue is not related to amount of virus in that tissue 
indicating that prolonged viremia during PRRSV infection may be the result of 
ineffective T-cell recruitment and response (Xiao et al., 2004). 
Innate immunity 
The innate antiviral immune response lacks memory and antigen-specificity, 
but provides an initial barrier to limit viral replication and spread, as well as activate 
the adaptive immune response. The main cellular components of the lung airways 
involved in innate immunity include the epithelium, MOs and DCs. Peptide and 
proteins products, such as lysozymes, antimicrobial peptides, and defensins, 
produced by these cells are involved in protecting the lung from invading pathogens. 
Cytokines, such as interferon-alpha (IFN-a), tumor necrosis factor-alpha (TNF-a), 
and interleukins-1, 6, and 8 (IL-1, IL-6, IL-8) are produced during the early stages of 
infection, before the antigen-specific immune response is activated. These cytokines 
play a role in the early immune response by activating MO antimicrobial functions, 
inducing fever, and altering vascular permeability for subsequent cell infiltration, as 
well as having several other functions. During pulmonary viral infection, early 
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cytokines are produced by cells such as MOs or epithelial cells and work specifically 
in the lung, as they are not thought to diffuse elsewhere (Nelson et al., 1989). 
Cytokine production in the lungs of PRRSV infected pigs has been shown to 
be fairly modest when compared to animals infected with either swine influenza virus 
(SIV) or porcine respiratory coronavirus (PRCV). Whereas SIV infected pigs show a 
marked increase in bioactive TNF-a, IFN-a, and IL-1 in the bronchial-alveolar lavage 
(BAL) within a day of infection, PRRSV infected pigs only show an increase in IL-1 
that peaks approximately 7 days PI (Van Reeth et al., 1999). The level of IFN-a in 
the BAL is approximately 1,000 to 10,000-fold less in PRRSV infected pigs than SIV 
infected pigs, with less than 1000 U/ml detected (Van Reeth et al., 1999). Although 
SIV infection results in an acute, somewhat severe clinical disease, pigs typically 
clear the virus within a week. This indicates that while the innate immune response 
during SIV infection may induce pathological lesions, it does result in clearance (Van 
Reeth et al., 2002). On the other hand, PRRSV elicits a modest innate immune 
response (reviewed by (Murtaugh et al., 2002), and can persist in an animal for 
several months (Wills et al., 2003) 
Type I interferons, such as IFN-(3 and IFN-a, have an important role in the 
innate antiviral immune response. The production of IFN-a/(3 is triggered after the 
recognition of dsRNA, an intermediate of viral replication. Once produced, IFN-a/(3 
signals in an autocrine/paracrine manner for the production of antiviral mediators 
within the host cell. These antiviral proteins control viral replication by hindering viral 
protein translation and virion assembly. Two reports from separate laboratories 
described the lack of IFN-a production from PRRSV-infected cells and animals 
(Albina et al., 1998, Buddaert et al., 1998). In addition, both illustrated the protective 
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benefits of IFN-a by showing that the addition of recombinant IFN-a could inhibit 
PRRSV infectivity of alveolar MOs. However, these two groups differed on one key 
finding, and that was the ability of PRRSV to directly inhibit IFN-a production. Both 
groups used coronavirus [porcine respiratory coronavirus (PRCV) or transmissible 
gastroenteritis virus (TGEV)] to induce IFN-a production, and subsequently infected 
the cells or animals with PRRSV to determine if IFN-a levels were decreased by the 
PRRSV. In vitro, PRRSV did reduce the production of of IFN-a induced after TGEV 
infection (Albina et al., 1998); however, in vivo, PRRSV did not reduce the levels of 
IFN-a in the lavage of animals infected with PRCV (Buddaert et al., 1998). 
Recently, Lee et al. investigated both the induction of type I interferon 
production by various PRRSV isolates, as well as the susceptibility of these isolates 
to IFN-a (Lee et al., 2004). Interestingly, results indicated that field isolates differ in 
interferon induction and sensitivity. Variation of the IFN-a response induced by 
different PRRSV isolates may explain some of the discrepancies observed in the 
immune response between research groups. IFN-a has multiple effects on the 
adaptive immune response, for example, IFN-a can prevent activated T-cell death 
during infections (Marrack et al., 1999) and induce DC maturation (reviewed by 
(Tailor et al., 2006). Therefore, studies on the immune response(s) elicited by 
PRRSV may vary slightly when different isolates of PRRSV are used. 
HYPOTHESIS AND AIMS 
Taken together, there is mounting evidence that suggests the suboptimal 
adaptive immune response elicited to PRRSV is, in part, due to the weak activation 
of innate immune responses. Antigen-presenting cells (APC), such as MOs and 
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DCs, play a critical role in both the innate and adaptive antiviral immune response. 
APCs express receptors for recognizing conserved viral motifs such as double-
stranded RNA (dsRNA), and after recognition, rapidly produce cytokines for 
controlling viral replication. In addition, APCs can activate naïve T-cells for activation 
of the adaptive immune response for subsequent viral clearance and immunological 
memory. The response of alveolar MOs to PRRSV is particularly important because 
it is the primary cell in which PRRSV replicates. 
The underlying hypothesis for the work contained in this dissertation is that 
PRRSV is relatively undetected by APCs during the early stages of disease; 
consequently, PRRSV replicates unchecked in the host. Uncontrolled PRRSV 
replication results in a gradual development of the adaptive immune response and a 
delay in the clearance of virus from the host. Although it has been shown that IFN-a 
can inhibit PRRSV replication in alveolar MOs in vitro, very few studies have 
specifically investigated the innate immune response of APCs to PRRSV. In 
addition, there is very little information available on the innate antiviral immune 
response of porcine MOs in response to dsRNA. Results from such studies would be 
valuable for gaining insight into PRRSV immunity and may also provide information 
useful for studies of other respiratory viruses. 
The specific aim of the first two chapters and the short study contained in the 
appendix was to detail the activation of the type I interferon response of porcine lung 
DCs and alveolar MOs to PRRSV or dsRNA. In addition, these studies were 
designed to investigate the effects of IFN-a on inducing activation of the antiviral 
immune response. Information gained from these studies will be helpful for 
identifying the mechanism(s) by which PRRSV evades the host immunity and may 
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provide information necessary for the rational design of vaccine adjuvants or other 
therapeutic targets. 
The final chapter of the dissertation investigated the innate antiviral immune 
response to PRRSV in vivo, and correlated the affect of virus quantity on this 
response. In vivo pathogenicity is often ascribed solely to the ability of a viral isolate 
to replicate in the host; however, studies have not yet critically addressed the effects 
of PRRSV inoculum dose on the immune response. The final study was set up to 
investigate the type I interferon response of alveolar MOs in vivo and to determine if 
the antiviral immune response correlated to inoculum dose. 
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Figure 1: Overview of TLR3 and type I interferon signaling. 
Toll-like receptor 3 (TLR3), expressed in the endosome, recognizes double-stranded 
RNA (dsRNA) and signals production of IFN-|3 and proinflammatory cytokines via 
the MyD88-dependent and independent pathways. Type I interferon (IFN-a/(3) binds 
type I interferon receptor (IFNAR) and initiates the Jak-STAT signaling pathway for 
transcription of interferon-stimulated genes (ISG), such as Mx, PKR, and MHC. 
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Figure 2: Overview of type I interferon response during viral infection. 
Toll-like receptor 3 (TLR3), expressed in the endosome, recognizes double-
stranded RNA (dsRNA) and signals production of IFN-(3 and via the MyD88-
dependent and independent pathways (TRIF). Double-stranded RNA dependent 
protein kinase (PKR), expressed in the cytoplasm, also acts a dsRNA sensor and 
induces transcription of IFN-0. Once secreted, type I interferon (IFN-a/p) binds 
type I interferon receptor (IFNAR), which signals via the Jak-STAT signaling 
pathway. Phosphorylated STAT-1:STAT-2 translocates into the nucleus and binds 
to interferon-regulatory factor 9 (IRF-9), becoming the complex interferon-
stimulated gene factor 3 (ISGF-3). ISGF-3 binds to DNA consensus sequence 
referred to as interferon-stimulated response element (ISRE), which is present in 
the promoter region of several genes. Overall, IFN-a/p induces the transcription of 
various antiviral genes, including Mx and PKR, as well as immunomodulatory 
genes, such as MHC. 
29 
VIRUS 
RECOGNITION 
lMyD88 
MX 
..t PKR 
MHC 
IRF-9 P 
IFNAR 
TYPE I 
INTERFERON 
RESPONSE 
* Virus X TLR3 
dsRNA <$> IFN-a/p 
30 
CHAPTER 2: DIFFERENTIAL TYPE I INTERFERON ACTIVATION AND 
SUSCEPTIBILITY OF DENDRITIC CELLS TO PORCINE ARTERIVIRUS 
A manuscript submitted to Immunology 
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SUMMARY 
Dendritic cells (DCs) play a role in antiviral immunity by providing early innate 
protection against viral replication and by presenting antigen to T-cells for initiation of 
the adaptive immune response. Studies show the adaptive response to porcine 
reproductive and respiratory syndrome virus (PRRSV) is ineffective for complete 
viral elimination. Other studies describe the kinetics of the adaptive response to 
PRRSV, but have not investigated the early response by DCs. We hypothesize that 
there is an aberrant activation of DCs early in PRRSV infection; consequently, the 
adaptive response is inadequately triggered. The current study characterized a 
subtype of porcine lung DCs (L-DCs) and investigated the ability of PRRSV to infect 
and replicate in L-DCs and monocyte-derived DCs (MDDCs). Furthermore, the type I 
interferon antiviral response to PRRSV with and without the addition of recombinant 
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porcine IFN-a (rpIFN-a), an important cytokine that signals for antiviral mediator 
activation, was analyzed. Results show that PRRSV replicated in MDDCs but not L-
DCs, providing evidence these cells have followed distinct differentiation pathways. 
Although both cell types responded to PRRSV with an induction of IFN-(3 mRNA, the 
magnitude and duration of the response differed between cell types. The addition of 
rpIFN-a was protective in MDDCs, and mRNA synthesis of Mx and PKR was 
observed in both cell types after rpIFN-a addition. Overall, PRRSV replicated in 
MDDCs but not L-DCs, and rp IFN-a was required for the transcription of protective 
antiviral mediators. DC response to PRRSV was limited to IFN-p transcription, which 
may be inadequate in triggering the adaptive immune response. 
INTRODUCTION 
Porcine reproductive and respiratory syndrome virus (PRRSV) is an 
enveloped, single-stranded, positive-sense RNA virus belonging to the Arteriviridae 
family. It is an important infectious disease agent in pigs worldwide, causing 
reproductive failure in pregnant sows and respiratory problems in young piglets. In 
vivo, PRRSV replicates primarily in alveolar macrophages but has also been shown 
to replicate in blood monocytes and monocyte-derived macrophages in vitro \ The 
course of infection includes an acute viremic stage, lasting approximately one 
month, followed by a chronic stage in which viremia resolves, but virus can still be 
isolated from secondary lymphoid tissues 2. Virus has been reported to persist in 
some animals for months, with and without shedding 3,4 
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During the course of disease, anti-PRRSV antibody can be detected by a 
week post-infection; however, neutralizing antibodies do not appear until 4 weeks 
post-infection or later5. Cell-mediated immunity, measured as antigen-specific 
lymphocyte proliferation, is not detected until 4 weeks after infection 6| 1. Antigen-
specific gamma interferon (IFN-y) secreting T-cells can be measured at 2 weeks 
post-infection; but, this response is quite variable among animals 8 and can take 
nearly 6 months to peak9. Attenuated PRRSV vaccines have been shown to prevent 
morbidity associated with disease and provide protection when pigs are challenged 
with a homologous strain of the virus 10. However, vaccination does not prevent 
disease nor protect against heterologous strains of the virus 11. Overall, the early 
adaptive immune response to PRRSV is weak and results in delayed elimination of 
virus from the host12 Unprotected healthy animals may acquire virus from non­
clinical shedders 13 and infected animals can become susceptible to secondary 
infections 14,15. 
Type I interferon (IFN-a/p) is critical for innate control of virus replication as 
well as activation of the adaptive immune response 16. Upon viral invasion, IFN-a/(3 
is synthesized, secreted, and signals through the type I interferon receptor (IFNAR), 
inducing transcription of several antiviral mediators, including PKR (double-stranded 
RNA dependent protein kinase) and Mx (myxovirus resistant; IFN-inducible 
GTPase). Viral stimulation, independent of interferon signaling, can also stimulate 
the expression of various antiviral proteins through the activation of toll-like receptors 
(TLR) and other undescribed signaling pathways 17. PKR, Mx, and other antiviral 
proteins function to hinder viral replication by blocking protein translation or altering 
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cell signaling 18. Once produced, IFN-a/(3 can induce dendritic cell (DC) maturation 
19
, and act as a survival factor for activated T-cells20,21. DC maturation in response 
to double-stranded RNA or viral infection requires IFN-a/|3 22, and IFN-a/p stimulates 
resistance in DCs to viral cytopathic effects 23. Several ON A and RNA viruses are 
capable of infecting DCs and have adapted mechanisms to modulate the host 
response 24. These studies, and others, indicate an important role for IFN-a/p during 
an immune response. 
Overall, DCs have a pivotal role in host defense against viral infections and 
subsequent activation of the adaptive response. Studies are needed to investigate 
the innate response of DCs to PRRSV as well as identify ways in which the virus can 
interfere with host defenses. This is important for understanding PRRSV-induced 
pathogenesis and for the development of protective vaccines. Evidence, as 
previously discussed, suggests that the early adaptive immune response to PRRSV 
is suboptimal and we hypothesize that this is due to the lack of IFN-a/p production 
by dendritic cells after infection. Thus, the following study investigated the 
susceptibility of MDDCs and L-DCs to PRRSV, assessed type I interferon activation 
after infection, and investigated the protective effects of IFN-a on both DC 
populations. 
MATERIALS AND METHODS 
Animals 
Conventionally reared, mixed breed, 4- to10-week-old pigs were used for these 
experiments. They were housed in isolation rooms at the National Animal Disease 
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Center under the approval of the Institutional Animal Care and Use Committee. 
Four animals per experiment were used and the number of replicates is noted in 
each figure. 
Lung dendritic cells 
The L-DC isolation procedure employed was based on previous reports of lung 
dendritic cell isolation in other species, with several modifications25. Pigs were 
anesthetized with a combination of ketamine and xylazine given intramuscularly. 
Peripheral blood was drawn from the cranial vena cava and animals were 
subsequently euthanized with an overdose of pentobarbital given intravenously. The 
pulmonary vasculature was flushed with sterile PBS to remove peripheral blood. 
This was accomplished by exposing the thoracic viscera and clamping the trachea 
and double clamping the esophagus and caudal vena cava before severing to avoid 
gross contamination of the lung. The pulmonary artery was clamped, a canula was 
inserted distal to the clamp, and the vasculature was flushed with 300 ml of sterile 
PBS that was allowed to drain through the severed aorta. The lungs were 
subsequently removed and the airways were lavaged with 200 ml of sterile PBS to 
eliminate cells in the airways. Lung lobes were detached from the bronchi and 
trachea and submerged in sterile PBS until further processing. 
Lung dendritic cell enrichment 
Each lung lobe was minced into small pieces and incubated with Liberase Blenzyme 
3 (17.5 mg) (Roche) and Deoxyribonuclease I (50 pg/ml) (Sigma) in 100 ml PBS on 
an orbital shaker at 37°C for 75 minutes. Released cells were collected; fetal bovine 
serum was added to a final concentration of 20%, cells were centrifuged at 400xg for 
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15 minutes, and subsequently fractionated by density gradient separation as 
previously described for splenic dendritic cells26. Collected cells were used as lung 
DC-enriched fraction.26 
F ACS Sorting 
The lung DC-enriched fraction was sorted for cells expressing CR4 (CD11c) by 
fluorescence activated cell sorting (FACS). Cells (2x108) were stained with 5 jjg of 
anti-CR4(CD11 c)-PE (S-HCL3, BDPharmingen) for 15 minutes on ice in the dark. 
Cells were washed twice with PBS/2%FCS, sorted based on forward scatter and 
side scatter and CR4 (CD11c) expression on a FACSAria (Becton Dickinson). 
Sorted lung dendritic cells (L-DCs) were consistently 90%-94% CR4(CD11c)+. 
Monocyte-derived dendritic cells and macrophages 
Monocyte-derived dendritic cells were derived as previously described 27. Briefly, 
peripheral blood mononuclear cells were collected from blood by isolating the buffy 
coat after density centrifugation with Histopaque-1077 (Sigma). Monocytes were 
isolated by plastic adherence after overnight incubation and subsequently cultured 
with recombinant porcine GM-CSF (5ng/ml) and recombinant porcine IL-4 (2ng/ml) 
(R&D Systems). Half of the media was replaced every third day, and cells were 
collected on the seventh day and used as MDDCs. Monocyte-derived macrophages 
(MDMO's) were derived in a similar manner, but cultured without the addition of 
cytokines. Cells were collected on the seventh day and used as MDMO's. 
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Cell Characterization 
Phenotyping 
MDDCs and the lung DC-enriched fraction were phenotyped using flow cytometry. 
Staining was carried out as previously described 27. The following antibodies, 
purchased from VMRD, were used: anti- CD14 (CAM36A), MHCII (MSA3), MHCI 
(PT85A), CD16 (FcG7), CR4 [(CD 11c) (S-HCL-3)], CD172a-SWC3a (74-22-15A), 
CD1 (76-7-4). CD80/86 expression was determined using hCTLA4-mouse 
immunoglobulin fusion protein (Ancell). Secondary antibodies, targeted to murine 
primary antibodies, included lgG1-APC, lgG2a-FITC, and lgG2b-PE. Data was 
acquired using CellQuest Pro software (BD Biosciences) on a LSR flow cytometer 
(Becton Dickinson) and analyzed using FlowJo software (TreeStar). 
Electron Microscopy 
Freshly sorted L-DCs or MDDCs were fixed in 2.5% glutaraldehyde, postfixed in 1% 
osmium tetroxide, and embedded in Eponate 12 (Ted Pella, Inc). Ultrathin sections 
were cut and stained with Reynold's uranyl acetate and lead citrate. Sections were 
examined using an electron microscope (FEI Tecnai 12, Birtwin). 
Tracer Endocytosis 
Freshly sorted L-DCs or MDDCs were cultured at 4x105 cells/200 pl/well in a 96-well 
round-bottom plate with cell culture media [RPMI 1640, 2 mM L-glutamine, 1X 
antibiotic/antimycotic (all from Invitrogen), 100ug ml"1 Gentamicin and 10% FCS 
(Atlanta Biologicals)]. Fluorescently tagged antigens were purchased from Molecular 
Probes. Dextran-Alexa Fluor® 488 and Ovalbumin-Alexa Fluor® 647 were used at 
100 jjg ml"1 and LPS-Alexa Fluor® 488 was used at 1pg ml"1. Cells were incubated 
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with antigen for 90 minutes at both 37 °C and 4 °C. Tracer uptake was stopped by 
the addition of ice-cold FACS buffer (PBS, 2% FCS, 0.2% sodium azide). Data is 
expressed as the mean fluorescence intensity of cells incubated at 37°C minus the 
mean fluorescence intensity of cells incubated at 4 °C. 
Allogeneic T-cell stimulation 
T-cells were sorted by magnetic activated cell sorting (MACS) (Miltenyi Biotec 
GmbH) after labeling with CD3 (8E6) antibody followed by secondary antibody 
conjugated to magnetic beads. Purity of CD3+ cells isolated was 93-97% after 
passage over two magnetic columns. CD3+ lymphocytes were labeled with the 
fluorochrome 5,6 carboxyfluorescein diacetate succinimidyl ester (CFSE) according 
to manufacturer's recommendations (Molecular Probes). L-DCs and MDDCs were 
mitomycin C treated prior to addition of CFSE labeled CD3+ lymphocytes. MDMO's 
were used as a control cell type. For treatment studies, L-DCs were incubated for 18 
hours with 50 |jg ml"1 polyriboinosinic:polyribocytidylic acid (polylC; Amersham 
Biosciences), PRRSV (MOI=1), or PRRSV plus rplFN-a prior to the addition of 
CFSE-labeled T-cells. Incubations at 1:2 or 1:10 T-cells to dendritic cells were 
carried out for 5 days in duplicate. CFSE fluorescence intensity was measured on a 
LSR flow cytometer and data analyzed using FlowJo software. Stimulatory capacity 
was assessed as the percentage of daughter T-cells generated in the mixed 
leukocyte reaction. 
Cellular Response 
Viruses 
PRRSV (NADC-8)28 from fourth passage on MARC-145 cells was used in the 
current study. The influenza A/swine/Texas/4199-2/98 (TX/98, H3N2 subtype) and 
influenza A/swine/lowa/15/30 (IA/1930, H1N1 subtype) was used after passage on 
Madin-Darby canine kidney (MDCK) type II cells (kindly provided by Dr. Amy 
Vincent). Porcine respiratory coronavirus (PRCV) was isolated from a swine herd in 
Iowa and used after passage on swine testicular (ST) cells (kindly provided by Dr. 
Kelly Lager). 
Antigen-presenting cell stimulation 
L-DCs and MDDCs were plated at 3.5x105 cells/500|jl/well in a 48-well plate. For 
stimulation, PRRSV was given at a multiplicity of infection (MOI) of 1, recombinant 
porcine alpha-interferon (IFN-a) (Biosource) was used at 200 U ml"1, and where 
indicated, given simultaneously. Synthetic double-stranded RNA, or 
polyriboinosinic:polyribocytidylic acid (polylC; Amersham Biosciences), was used at 
50 pg ml"1. Supernatant was collected at various times post-infection for 
extracellular virus quantification. Cells were collected at the same time points in RLT 
buffer (Qiagen RNeasy Kit) for RNA extraction. Intracellular staining for PRRSV 
ORF-7 was carried out as previously described29 with few modifications. Briefly, cells 
were fixed with ICFix (Biosource) for 15 minutes, washed twice with FACS buffer, 
and permeabilized with 0.1% saponin (w/v) in FACS buffer for 15 minutes. Cells 
were again washed and incubated with FITC-conjugated anti-PRRSV (SDOW-17, 
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Rural Technologies Incorporated) for another 15 minutes. Cells were washed and 
immediately analyzed on a LSR flow cytometer (Becton Dickinson). 
Cytokine gene expression 
RNA was isolated from cells (Qiagen RNeasy Mini kit), cDNA was synthesized with 
random primers (Invitrogen), and SYBR green based real-time PGR was carried out 
for various mRNA targets according to manufacturer's recommendations (SYBR 
Green Master Mix, Applied Biosystems). Briefly, cDNA, SYBR green master mix and 
primers (final concentration 600nM) were mixed in a 20 pi reaction and cycled as 
follows: 95 °C for 15 minutes, 95 °C for 15 seconds followed by 50 °C for 1 minute 
(45 cycles) and a final dissociation step. All samples were run in duplicate. Levels of 
mRNA were calculated using the 2"MCt method, which expresses mRNA in treated 
cells relative to mock infected cells after normalizing to (3-actin30. PGR products were 
less than 100 base pairs in size and primers were as follows (5' to 3'): (3-actin-
forward CTCCTTCCTGGGCATGGA, (3-actin-reverse CGCACTTCATGATCGAGTTGA; IFN-(3-
forward TGCAACCACCACAATTCC, IFN-(3-reverse CTGAGAATGCCGAAGATCTG; IFN-a-
forward GCCTCCTGCACCAGTTCTACA, IFN-a-reverse TGCATGACACAGGCTTCCA; Mx-1-
forward TAGGCAATCAGCCATACG, Mx-1-reverse GTTGATGGTCTCCTGCTTAC; PKR-
forward GAGAAGGTAGAGCGTGAAG, PKR-reverse CCAGCAACCGTAGTAGAG. Primers 
were generated using Primer Express, purchased from Integrated DNA 
Technologies (IDT), and primer pair efficiency confirmed using the method described 
by Livak and Schmittgen, 200130. 
Virus quantification 
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To determine the levels of live, extracellular virus, end point titrations were 
performed using MARC-145 cells, a monkey kidney cell line permissive to PRRSV, 
and quantified using the Reed and Muench method. Results were converted to logio 
values for graphing and statistical analysis. To determine amounts of extracellular 
viral RNA (vRNA), Qiagen's QIAamp Viral RNA mini kit was used to isolate vRNA 
from the supernatant collected after PRRSV stimulation and quantified using real­
time RT-PCR. 
PRRSV real-time PCR 
A real-time PCR assay for PRRSV (J. Richt et al., unpublished data) was utilized for 
vRNA quantification as follows. Briefly, a one-step PCR kit was used with a few 
modifications from manufacturer's protocol (Qiagen). Each reaction contained the 
following: 8 pi of template or standard RNA, 0.4 pmol each of forward and reverse 
primer, 0.1 pM probe, 400 pM each dNTP, 5 pg non-acetylated bovine serum 
albumin (Sigma), 5.5 mM MgCh, 2.5 U RNase inhibitor (Invitrogen), one-step PCR 
buffer (5 pi), and enzyme mix (1 pi). Reactions were performed in a final volume of 
25 pi and cycling parameters set as follows: 50 °C for 30 minutes; 95 °C for 15 
minutes; 45 cycles of 94 °C for 15 seconds followed by 60 °C for one minute with 
fluorescence detected during this final step. Primers and probe were generated 
using Primer Express and purchased from Integrated DNA Technologies (IDT) and 
the generated PCR product was 105 base pairs. Primers and probe sequences (5' to 
3') are as follows: PRRSV-forward T C AGCT GT GCC AG AT GCTGG, PRRSV-reverse 
AAATGGGGCTTCTCCGGGTTTT, PRRSV-probe FAM-TCCCGGTCCCTTGCCTCTGGA-
Blackhole Quencher. 
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In vitro transcribed ORF-7 gene RNA was used to set up a standard curve of vRNA 
copy number for vRNA quantification. The PRRSV ORF-7 gene was cloned into 
pCRII-TOPO (Invitrogen) and transcribed using the Ribomax™ Large Scale RNA 
Production kit (Promega). Transcribed RNA (cRNA) was DNase-treated (Ambion), 
quantified by spectrophotometry, and cRNA concentration was converted to 
molecular number31. Tenfold serial dilutions of cRNA were used for generating a 
standard curve and corresponded to 2.5 x 102 to 2.5 x 10® copy numbers. Results 
were converted to logi0 values for graphing and statistical analysis. 
Statistical analysis 
A student's t-test was used for statistical analysis. P-values < 0.05 are noted in 
figures. 
RESULTS 
Dendritic cell characterization 
CR4 (CD 11c) expressing cells were isolated from the lungs of healthy pigs 
and assessed for DC characteristics. Morphological features from transmission 
electron micrographs showed L-DCs had a large nucleus, scant cytoplasm, and 
fingerlike plasma membrane extensions, and similar traits were observed in 
monocyte-derived dendritic cells (MDDC) (figure 1). The surface phenotype of 
MDDCs and L-DCs was determined using flow cytometry. Scatter profiles (figure 2) 
indicated that L-DCs and MDDCs were forward scatter high. L-DCs were more 
granular and complex than MDDCs (high orthogonal profile). As previously shown 27, 
MDDCs were MHC class l+, MHC class ll+, and CR4(CD11c)+ (figure 2b, data not 
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shown). MDDCs also expressed CD16, CD14 and low levels of CD80/86 (figure 2b). 
L-DCs, which were sorted on CR4(CD11c), expressed MHC class I and CD80/86. 
More than 50% of L-DCs were MHC class ll+ and CD16+, with only a small fraction 
expressing CD14 (figure 2a). In addition, MDDCs and L-DCs were CD172a+ and 
CD1+ (data not shown). 
DCs are distinguished as antigen processing and presenting cells by the 
specialized uptake of small molecules via defined pathways, including receptor 
mediated endocytosis and macropinocytosis. Antigen uptake was assessed in both 
L-DCs and MDDCs using tracer endocytosis. For this assay, the uptake of 
fluorescently labeled antigens [dextran, lipopolysaccharide (LPS), and ovalbumin] 
was determined by flow cytometry. L-DCs were able to phagocytize all antigen 
types tested (figure 3a). In L-DCs, ovalbumin antigen uptake was the greatest and 
only low amounts of LPS were phagocytized. Although MDDC uptake of dextran and 
LPS was minimal, MDDCs were still able to uptake antigen via receptor-mediated 
endocytosis as noted by uptake of ovalbumin to quantities similar to L-DCs (figure 
3a). 
In addition to antigen uptake, DCs are known for the ability to stimulate 
naïve T-cell proliferation in a mixed leukocyte reaction. L-DCs, MDDCs or MDMO's 
were used as stimulators of unprimed allogeneic CD3+ lymphocytes to determine 
each cell types ability to stimulate T-cell proliferation. Responder cells (CD3+) were 
labeled with the fluorochrome 5,6 carboxyfluorescein diacetate succinimidyl ester 
(CFSE) to assess proliferation of these cells 32. As the parent population proliferates, 
the dye is distributed equally to daughter cells and fluorescence decreases. Figure 
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3b shows that after 5 days, more than 40% of the parent population had proliferated 
when stimulated by L-DCs or MDDCs at 1:10 ratio (responderstimulator). However, 
MDMO's induced less than 30% of the T-cells to proliferate at the same 1:10 ratio. 
Approximately 30% of T-cells had proliferated when stimulated by L-DCs at 1:2, but 
only about 10% proliferated in response to MDDCs and MDMO's at the same 
stimulator to responder ratio. 
PRRSV infectivity of dendritic cells 
L-DCs and MDDCs were incubated with PRRSV to determine if DCs are 
permissive to the virus. Intracellular staining for PRRSV nucleocapsid protein 
(ORF7) was done at 18-hours post-inoculation. The forward and side scatter 
properties at 18-hours indicated a live cell population for both cell types and 
intracellular PRRSV was detected in MDDCs but not L-DCs (figure 4). At 24 and 36 
hours post-inoculation, L-DCs remained viable by forward and side scatter profile, 
but intracellular ORF7 protein could still not be detected (data not shown). PRRSV 
was cytolytic to MDDCs making intracellular detection of PRRSV difficult at later time 
points (e.g. 36 hours). As IFN-a has been shown to hinder viral replication, we tested 
the ability of recombinant porcine alpha-interferon (rplFN-a) to inhibit PRRSV 
infection of MDDCs. When rplFN-a was added to MDDCs at the time of virus 
inoculation, intracellular PRRSV could not be detected at 18 hours post-infection 
(figure 4b, dotted line). 
Supernatant from L-DCs and MDDCs was collected at 0, 12, 24, and 36 
hours post-inoculation to quantify extracellular live virus by end-point titration on 
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MARC-145 cells and vRNA by real-time PCR (figure 5). Extracellular levels of live 
PRRSV and vRNA increased significantly by 12 hours post-infection in MDDCs and 
peaked at 24 hours (figure 5b). The amount of extracellular live virus or vRNA 
measured over time did not change when rp IFN-a was added to MDDCs at the time 
of virus inoculation (figure 5b, d), indicating a protective effect of IFN-a. Levels of 
virus did not change over time in L-DCs when measured by titration or real-time 
PCR, demonstrating that PRRSV did not replicate in these cells. However, the 
addition of rplFN-a inhibited the ability to detect live virus in supernatant from L-DCs 
(figure 5a). This difference was not detected when virus was quantified by real-time 
PCR, indicating vRNA levels in the supernatant did not change (figure 5c,d). Overall, 
this data shows that PRRSV replicated in MDDCs, but not in L-DCs, and that IFN-a 
can inhibit PRRSV replication in permissive cells. 
Type I interferon response 
IFN-a induces the transcription of several antiviral mediators, including PKR 
and Mx. L-DCs and MDDCs were stimulated with PRRSV, rplFN-a, or PRRSV plus 
rplFN-a to investigate DC antiviral responses and the role of IFN-a in inducing an 
antiviral state. In addition, rp IFN-a was used to determine if PRRSV could inhibit the 
effects of IFN-a on DCs. At 12 and 24 hours post-stimulation, mRNA levels of IFN-(3, 
IFN-a, Mx, and PKR were measured and compared to levels in uninfected cells. 
Figure 6 shows L-DCs and MDDCs responded to PRRSV with increased 
transcription of IFN-(3. At 12 hours there was an average 25-fold increase in IFN-(3 
mRNA levels in PRRSV treated DCs compared to mock infected cells. By 24 hours 
PI, the amount IFN-jB mRNA had decreased in L-DCs, but was even higher in 
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MDDCs. L-DCs treated with polylC showed similar transcription of IFN-{3 as when 
treated with PRRSV (figure 6a). However, stimulation of L-DCs with SIV or PRCV 
did not induce changes in any mRNA transcripts measured in these studies. Overall, 
L-DC transcription in response to any viral stimulus used was limited to IFN-|3, which 
occurred only when exposed to PRRSV or polylC. There was no alteration in IFN-a, 
Mx, or PKR transcript in either cell type when stimulated with polylC or PRRSV only. 
The amount of Mx or PKR mRNA only increased in cells treated with rplFN-a 
and levels were similar even when PRRSV was present. This data suggested that 
PRRSV did not hinder the antiviral response induced by IFN-a. The magnitude of 
increased Mx and PKR was greater in MDDCs than that of L-DCs and was 
sustained in MDDCs overtime, indicating that MDDCs may be more responsive to 
IFN-a than L-DCs. At 12 hours post-stimulation, IFN-|3 levels in L-DCs treated with 
PRRSV or PRRSV plus rpIFN-a were higher than when stimulated with rplFN-a 
only. The addition of rplFN-a did not appear to induce IFN-|3 transcription in L-DCs, 
but instead IFN-|3 was elevated mainly in response to PRRSV. By 24 hours post-
stimulation, L-DC IFN-|3 mRNA levels were near baseline in cells treated with both 
PRRSV plus rplFN-a, but not in cells treated only with PRRSV. L-DCs stimulated 
with polylC or PRRSV only still had increased levels of IFN-P mRNA (figure 6a) at 24 
hours. 
The addition of rplFN-a did induce IFN-(3 transcription in MDDCs, evident at 
12 and 24 hours post-infection. At 12 hours post-stimulation, IFN-p transcription was 
greatest in cells treated with both PRRSV and IFN-a. By 24 hours post-infection, 
MDDC IFN-(3 mRNA levels were similar in cells treated with PRRSV alone or 
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PRRSV plus rplFN-a. Levels of IFN-a mRNA did not significantly change in either 
cell type with any treatment. 
L-DC changes in response to PRRSV 
To investigate phenotypic and functional changes to L-DCs due specifically to 
PRRSV exposure, cells were incubated with either polylC, swine influenza virus 
(SIV), PRRSV, or PRRSV plus rplFN-a for 18 hours before assessing MHC class I 
and CD80/86 expression. PolylC stimulation did not alter MHC-I expression, but did 
induce the upregulation of the costimulatory molecules CD80/86. There was no 
change in MHC-I or CD80/86 expression after SIV exposure (data not shown). 
PRRSV did not induce changes in CD80/86 expression in comparison to sham 
treated cells, but did cause a downregulation of MHC-I expression (figure 7). This 
effect was more profound after 36-hours of stimulation (data not shown). The 
addition of rpIFN-a with PRRSV did stimulate an increase in MHC-I and CD80/86 
expression, showing it can counteract the negative effects of PRRSV on L-DC 
phenotype. 
To determine whether the decrease in MHC-I expression after incubation with 
PRRSV translated into alterations of dendritic cell function, an allogeneic mixed 
leukocyte reaction was done. L-DCs were exposed to various stimuli (polylC, 
PRRSV, or PRRSV plus rp IFN-a) or left untreated (sham) for 18 hours prior to the 
addition of CFSE labeled CD3+ T-cells. Figure 7b shows that the ability of L-DCs to 
stimulate allogeneic T-cell proliferation did not change with any treatment tested. 
Stimulated L-DCs mixed with T-cells at a ratio of 2:1 induced nearly 50% of the T-
cells to proliferate, similar to L-DCs that were left untreated. In addition, mixing cells 
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at a ratio of 10:1 (L-DC:T-cell) did not change the results; it only increased the 
percentage of T-cells in the daughter population. Nearly 80% of the T-cells 
proliferated at a 10:1 ratio regardless of pretreatment. Overall, stimulation of L-DCs 
with polylC, PRRSV or PRRSV plus rp IFN-a did not alter the DCs ability to stimulate 
allogeneic T-cell proliferation. 
DISCUSSION 
This is the first report describing a subpopulation of porcine lung dendritic 
cells (L-DCs) and results indicate that these cells may be inadequately activated 
during PRRSV infection. There was a difference in the susceptibility of MDDCs and 
L-DCs to PRRSV, but the addition of rplFN-a induced distinct, but beneficial, antiviral 
pathways in both cell types. Exogenous IFN-a may be required to adequately 
activate DCs during PRRSV infection. 
The different lineage pathways of MDDCs and L-DCs may explain why 
MDDCs were susceptible to PRRSV infection and L-DCs were not. PRRSV has a 
restricted tropism for subpopulations of monocytes/macrophages and various stages 
of differentiation and activation affects the susceptibility of these cells 33. It has been 
shown that macrophages residing in different locations of the body show different 
susceptibility to PRRSV34. MDDCs and tissue DCs follow distinct differentiation 
pathways and consequently, differ in response to various stimuli35,36. The MDDCs 
used in this experiment exhibited phenotypic (MHCdim, CD80/86dim) and functional 
(ovalbumin uptake) characteristics of immature dendritic cells, which may have a 
played a role in PRRSV susceptibility; however, L-DCs displayed functional 
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characteristics (dextran and ovalbumin uptake) of immature DCs as well. Therefore, 
it is difficult to determine from these studies if DC maturity has a role in susceptibility 
to PRRSV infection. It is possible that MDDCs display morphological, phenotypic 
and functional characteristics of DCs, but retain lineage characteristics of monocytes 
or macrophages that leave them susceptible to PRRSV. 
Although PRRSV infection or replication in L-DCs was not detected using 
described methods, PRRSV did alter L-DC phenotype. PolylC, a synthetic double-
stranded RNA representing an intermediate of viral replication, did not induce 
changes in MHC-I expression, whereas PRRSV induced a decrease in MHC-I 
expression. In addition, CD80/86 expression increased in the majority of polylC 
stimulated cells but did not change in PRRSV treated cells. On the other hand, SIV 
did not alter MHC-I or CD80/86 expression (data not shown). Thus, the modulation 
of activation antigens observed is unique to PRRSV. The addition of rp IFN-a with 
PRRSV counteracted the negative effects of the virus by inducing an increase in 
both MHC-I and CD80/86. Although this change in MHC-I did not translate into 
changes in the mixed leukocyte reaction, the decrease in MHC-I may reduce 
PRRSV antigen-specific presentation in vivo. 
As well as altering L-DC phenotype, it is possible that PRRSV may modify or 
utilize L-DCs in a manner bearing other immunological consequence, even without 
viral replication. For example, SARS-coronavirus does not replicate in DCs but can 
alter the cells sensitivity to LPS 37 In addition, DCs have been shown to harbor 
infectious porcine circovirus type 2 without severely modifying cell function 38. This 
would be advantageous to a virus because the DC could serve as a vessel of 
transport throughout the body while remaining anonymous to the immune system. 
PRRSV has been shown to persistent in lymphoid tissue for months after infection 
and the infected cell type has not yet been identified 12. PRRSV may utilize DCs for 
transport throughout the body, or possibly as a repository, leading to persistence. 
Further studies are needed to investigate the role of L-DCs in PRRSV-induced 
pathogenesis and to determine if L-DCs harbor PRRSV. 
Data presented in this study suggests a difference in the type I interferon 
response in MDDCs versus L-DCs when stimulated with PRRSV (reviewed in figure 
8). L-DCs and MDDCs both responded to PRRSV with the transcription of IFN-(3, but 
the magnitude of IFN-(3 transcription was greater in MDDCs than in L-DCs. Virus 
recognition between these two cell types may have occurred through different, but 
overlapping, mechanisms that resulted in differential lFN-(3 transcription. Virus can 
be detected by the specific interaction of envelope glycoproteins with host cell-
surface expressed's and/or detection of viral genome by endosomal TLR's22 and it 
has been shown that the induction of IFN-a/(3 production after viral stimulation is 
independent of replication39. It is likely that L-DCs and MDDCs responded to PRRSV 
with IFN-(3 transcription prior to virus replication, but the response in MDDCs was 
sustained due to the additional recognition of replication intermediates, such as 
double-stranded RNA. However, it is also possible that the variation in IFN-(3 
transcription between cells types is due to inherent differences between MDDCs and 
L-DCs. It has been shown that MARC-145 cells, a monkey kidney cell line, do not 
transcribe IFN-(3 in response to PRRSV 40, which differs from results presented here. 
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Again, as cells follow divergent differentiation pathways, they are likely to display 
distinct responsiveness to the same stimuli. 
It is unlikely that IFN-(3 mRNA transcribed in MDDCs or L-DCs after PRRSV 
stimulation was translated into functional protein because downstream genes were 
not transcribed. Type I interferon is often referred to as IFN-a/p because both IFN-a 
and IFN-|3 signal through the same receptor (IFNAR). IFN-(3 transcription is typically 
induced after viral stimulation and IFN-(3 protein is released and signals in an 
autocrine/paracrine manner for IFN-a transcription, as well as the transcription of 
other interferon-stimulated genes (ISO's) 41,42 The observation that IFN-(3 mRNA 
was not translated is supported by the observation that when MDDCs were 
stimulated with recombinant porcine IFN-a or recombinant human IFN-(31 (data not 
shown), levels of PKR and Mx mRNA increased. A lack of IFN-(3 translation has 
been described in murine alveolar macrophages after TLR activation, in which IFN-f3 
transcription was induced but protein was not synthesized or secreted 43.This is 
supported by the observation the L-DCs stimulated with polylC did increase IFN-(B 
transcription, but Mx-1 nor PKR transcription changed. Due to limited availability of 
reagents for porcine IFN-(3 we did not analyze IFN-p protein levels. However, Mx 
and PKR were not upregulated in cells with increased IFN-(3 mRNA transcript, 
providing indirect evidence that IFN-(3 was not translated. 
In addition to the differences in IFN-P transcription between the two dendritic 
cell types, the transcription of Mx and PKR was higher in MDDCs than L-DCs after 
stimulation with rplFN-a (figure 7). PRRSV alone did not induce the transcription of 
Mx or PKR, but instead the addition of rp IFN-a was required. The difference in the 
sensitivity of these two cell types to IFN-a may be due to differential expression of 
IFNAR between MDDCs and L-DCs. Also, signaling proteins that propagate the 
IFNAR signal may be expressed at different levels between cell types and this may 
account for the difference in Mx and PKR transcribed after the addition of exogenous 
IFN-a. Overall, the type I interferon response to virus in both cell types was limited to 
IFN-(3 transcription, and this is likely not enough to induce an antiviral state in DCs 
during PRRSV infection. 
It is interesting to note that the addition of rplFN-a to L-DCs at the time of 
PRRSV inoculation induced the L-DCs to release some type of antiviral compound. 
PRRSV did not replicate in L-DCs, indicated by the observation that the quantity of 
extracellular viable virus or vRNA did not change over time. However, when L-DCs 
were treated with rplFN-a, extracellular amounts of viable virus decreased but vRNA 
levels did not. It is possible that the addition of rplFN-a to L-DCs induced the 
expression of an antimicrobial peptide that was able to alter the integrity of live 
PRRSV because viable virus in the supernatant decreased over time, but the 
amount of vRNA did not. Antimicrobial peptides and proteins, including cathelicidins 
and defensins, are expressed by various mammalian cells and have been shown to 
have a role in innate host defense 44,45. Antimicrobial peptides and proteins are able 
to insert into membrane bilayers, form pores, and consequently compromise 
microorganism structure 46. A recent paper shows that surfactant protein 0 can bind 
HIV and inhibit virus replication 47. Expression of some antimicrobial peptides is 
constitutive, whereas others are produced in response to proinflammatory 
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cytokines48. Overall, IFN-a may induce L-DCs to produce an antimicrobial peptide or 
protein that is capable of affecting PRRSV viability. 
PRRSV infection did not activate the type I interferon response downstream 
of IFN-P transcription and any antiviral activity measured in MDDCs was dependent 
on the addition of rplFN-a. This data suggests that DCs can respond to IFN-a, but 
are not likely a major source of the cytokine after PRRSV exposure. L-DCs 
stimulated with polylC did increase IFN-(3 mRNA transcription, but only a minimal 
change in IFN-a transcription at 12-hours was observed, supporting the observation 
that L-DCs may not produce substantial quantities of IFN-a but can respond to 
exogenous IFN-a. In addition, L-DCs stimulated with swine influenza virus (SIV) or 
porcine respiratory coronavirus (PRCV) did not result in any change in IFN-(3, IFN-a, 
Mx-1, or PKR mRNA transcription at 12 or 24 hours (data not shown). Although it 
has been shown that circulating myeloid DCs do not produce IFN-a/p protein after 
stimulation with synthetic double-stranded RNA (polyl:C) or LPS 49, myeloid DCs 
derived from bone marrow (BM-DC) have been shown to produce IFN-a/(3 after 
stimulation with Semliki forest virus 39. Taken together, these data suggest that 
there may be inherent differences in the type I interferon responsiveness of tissue-
derived versus in wïro-derived myeloid DC subsets after viral exposure. 
The protective benefits of IFN-a during PRRSV infection was recently 
described in a study that showed a reduction in PRRSV infection after IFN-a was 
produced in response to porcine circovirus-2 50.The amount of IFN-a/(3 in the 
bronchial alveolar lavage fluid from pigs infected with PRRSV is quite low when 
compared to levels from pigs infected with SIV or PRCV51. SIV and PRCV infect 
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epithelial cells,52,53 which may be the source of type I interferon that leads to rapid 
and effective clearance of virus from the animal. Taken together, these studies 
indicate little IFN-a is produced in the lungs of PRRSV infected pigs although the 
presence of type I interferon would likely enhance the antiviral response. Exogenous 
IFN-a may be required to effectively trigger the anti-PRRSV immune response and 
adequately stimulate adaptive immunity for PRRSV clearance. 
In summary, we demonstrated that MDDCs, but not L-DCs, were susceptible 
to PRRSV infection and treatment with rplFN-a at the time of virus inoculation 
inhibited virus replication in MDDCs. PRRSV stimulated IFN-(B transcription in both 
dendritic cell types, but was of greater magnitude and duration in MDDCs. Although 
IFN-J3 transcription was stimulated, the usual type I interferon response to virus did 
not occur. PRRSV reduced MHC-I expression on L-DCs and the presence or rplFN-
a could reverse this effect and actually enhance MHC-I and CD80/86 expression. 
These results indicate that DCs may respond inadequately to PRRSV, leading to a 
suboptimal initiation of the adaptive immune response. Exogenous type I interferon 
may be required to induce an effective antiviral immune response during PRRSV 
infection. Further studies are warranted to determine the protective benefits of IFN-a 
during PRRSV infection and its potential as a therapeutic intervention during severe 
disease outbreaks. 
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Figure 1. Dendritic cell electron micrographs. Cell structure and 
morphology of freshly isolated (a) L-DCs and (b) MDDCs were 
examined by transmission electron microscopy. Dendritic processes 
and large nuclei can be seen in both cell types. 
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Figure 2. Dendritic cell phenotype. (a) CD11c+ cells from the lung-enriched 
fraction and (b) monocyte-derived dendritic cells were assessed for forward and 
side scatter properties and for the expression of indicated surface markers (grey 
histogram) by flow cytometry. Open histograms indicate isotype-controls. 
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Figure 3. Antigen-presenting cell (APC) function, (a) Fluorescently-labeled 
antigen uptake by L-DC's and MDDC's. Cells were incubated with labeled antigen 
for 90 minutes at 37°C or 4°C and fluorescence analyzed by flow cytometry. Data 
is expressed as mean fluorescence intensity difference in cells at 37°C to 4°C. (b) 
Stimulatory capacity of L-DC's, MDDC's and MDMO's. Allogeneic T-cell's were 
labeled with CFSE, mixed with APC's at various ratios, and the percentage of T-
cells that proliferated assessed at 5 days. Data is shown as mean ± SEM of 4 
animals and is a representative experiment out of two. 
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Figure 4. PRRSV infection of dendritic cells and IFN-a protection. L-DC's 
and MDDC's were infected with PRRSV at M0I=1 and analyzed by flow 
cytometry at 18 hour post-infection for intracellular PRRSV. Thin line (-) 
uninfected cells, heavy line (—) PRRSV infected, and dotted line (•••) PRRSV 
plus rplFN-a. Data is a representative of two experiments. 
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Figure 5. PRRSV replication in dendritic cells and IFN-a protection. 
Extracellular virus quantification using end-point titration and real-time PGR. (a,c) 
L-DC's and (b,d) MDDC's were infected with PRRSV at MOI=1 with (•) and 
without (•) 200U/ml rplFN-a. Supernatant was collected at various times post­
infection and analyzed for virus load using end-point titration (a,b) and real-time 
PCR (c,d). Data is shown as mean ± SEM of 4 animals and is a representative 
experiment out of two. 
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Figure 6. Type I interferon response to PRRSV and recombinant IFN-a. 
(a) L-DC's and (b) MDDC's were stimulated with 50 jjg/ml polylC (L-DC only), 
PRRSV at MOI=1, 200U/ml rplFN-a, or PRRSV+IFN-a, and transcription of 
IFN-(3, IFN-a, Mx-1 and PKR quantified by real-time PCR 12- and 24-hours 
later. Data is expressed as the mean ± SEM fold increase in gene expression 
relative to mock infected cells (dotted line). Data is a representative 
experiment out of three. 
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Figure 7: Phenotypic and functional changes in L-DC's after double-
stranded RNA (polylC) or PRRSV stimulation, (a) L-DC's were stimulated 
for 18 hours with polylC, PRRSV, or PRRSV plus IFN-a and expression of 
MHC-I and CD80/86 measured by flow cytometry. Data is expressed as the 
percentage mean fluorescence intensity relative to sham treated cells, (b) L-
DC's were treated with polylC, PRRSV, or PRRSV plus IFN-a for 18 hours 
before the addition of CFSE labeled allogeneic T-cells at noted ratios. T-cell 
proliferation was assessed at 5 days and data is expressed as the percentage 
of daughter T-cells generated in the mixed leukocyte reaction. 
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Figure 8. Proposed model in differential type I interferon response to 
PRRSV and recombinant IFN-a in MDDC's versus L-DC's. (a) Transcription 
of IFN-P in response to PRRSV occurred in both cell types, but stimuli was 
stronger in MDDC's (—) than L-DC's (•••). IFN-p did not appear to be translated 
because transcription of downstream interferon-stimulated genes (ISG's) did not 
occur, (b) The addition of recombinant IFN-a (rplFN-a) stimulated the 
transcription of ISG's (e.g., Mx and PKR) in both cell types, but MDDC's (—) 
were more sensitive than L-DC's (•••). Also, in MDDC's the addition of rp IFN-a 
triggered IFN-(3 transcription and hindered PRRSV replication. 
67 
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Abstract 
Pulmonary airways are relatively vulnerable to infection because of 
continuous exposure to antigen during respiration. The innate, antiviral response 
must be activated promptly, yet incisively, after pathogen recognition and alveolar 
macrophages (AM) likely play a role in this response. TLR3 and PKR recognize 
double-stranded RNA (dsRNA), a replication intermediate of RNA viruses, and 
initiate the transcription of type I interferons (IFN-a/(3). Synthetic dsRNA (polylC) was 
used to investigate the innate response of porcine AM and compared to that of 
peritoneal macrophages (PM). PolylC triggered production of IFN-a/f3 in AM and PM, 
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but levels in AM were significantly higher. However, transcription of interferon-
stimulated genes, Mx and PKR, was significantly higher in PM than AM. Lack of Mx 
and PKR transcription in AM was not due to deficient type I interferon receptor 
(IFNAR) signaling, as exogenous recombinant IFN-a induced translocation of 
phosphorylated STAT-1 into the nucleus. To investigate the differential mechanism 
by which IFN-a/(B transcription is activated in AM and PM, 2-aminopurine (2-AP) was 
used to block activation of PKR protein by dsRNA. IFN-a/p, Mx, and PKR mRNA 
levels in AM after polylC treatment were unaffected by 2-AP; conversely, 
transcription of IFN-a/p, Mx, or PKR remained at baseline in PM. Phosphorylated 
PKR was detected in PM, but not AM, in response to polylC. In addition to IFN-a/p 
gene induction, transcription TNF-a and RANTES was significantly greater in AM 
than PM after polylC stimulation. Overall, dsRNA recognition and subsequent 
signaling is likely mediated via TLR3 in AM and PKR in PM, resulting in unique gene 
induction patterns between different macrophage populations. 
Introduction 
As sentinels to host defense in the lung, alveolar macrophages (AM) are 
relatively vulnerable to infection because of continuous antigen exposure during 
respiration. AM are present in non-inflammed alveoli and are likely the first cell 
encountered in the lumen of the lower respiratory tract. Cytokines and chemokines 
produced by activated AM have an important role in providing early protection 
against pathogen dissemination and recruiting effector cells to sites of infection. 
Furthermore, AM can serve as APCs or antimicrobial effector cells. 
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Double-stranded (dsRNA) produced during viral replication is a pathogen 
associated molecular pattern (RAMP) of viruses and is recognized by host 
expressed pattern recognition receptors (PRR), e.g. toll-like receptors. Type I 
interferons (such as IFN-(3 and IFN-a) are critical for innate control of virus 
replication as well as activation of the adaptive immune response (1). Upon viral 
invasion, IFN-a/(3 is synthesized, secreted, and signals through the type I interferon 
receptor (IFNAR), inducing transcription of several antiviral mediators, including PKR 
(double-stranded RNA dependent protein kinase) and Mx (myxovirus resistant; IFN-
inducible GTPase). 
IFN-a/p production is induced after dsRNA binds to TLR3 in the host cell (2). 
TLR3 utilizes the adaptor proteins MyD88 (myeloid differentiation factor 88) and 
TRIF [Toll/IL-1 R (TIR) domain-containing, adapter inducing IFN-(3 protein; also 
referred to as TICAM-1] for transduction of activation signals (3). MyDBB-dependent 
signaling involves NF-KB activation for the transcription of proinflammatory 
cytokines, such as TNF-a (4). MyDBB-independent pathway of TLR3 signaling 
utilizes TRIF, which activates interferon regulatory factor (IRF)-3, IRF-7 (5, 6), and 
NFKB (4). IRF3 activates transcription of IFN-(3 and RANTES (receptor activated, 
normal T-cell expressed and secreted), whereas IRF-3 and IRF-7 are involved in 
IFN-a transcription (7-10). 
PKR is a serine/threonine kinase constitutive^ expressed in the cytoplasm, 
but can be upregulated in an interferon-dependent manner. PKR can induce the type 
I interferon response by phosphorylating IKB and subsequently activating the NFKB 
transcription factor (11, 12) or act as an antiviral mediator by limiting viral protein 
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translation (13). Thus, PKR can induce the production of IFN-a/p or act as mediator 
of the type I interferon response (13-15). Deciphering the role of PKR in the host 
immune response has been accomplished using a chemical compound, called 2-
aminopurine (2-AP). 2-AP specifically targets serine/threonine kinases and has been 
shown to specifically inhibit PKR function (16-19). 
Recent emergence of pathogenic influenza (H5N1) and severe acute 
respiratory syndrome coronavirus (SARS-CoV) heightens the need for studies 
investigating the activation and regulation of pulmonary antiviral immune response, 
particularly in AM. Increased cytokine production from H5N1 infected AM may play a 
role disease severity (20), but AM are critical for controlling influenza replication (21). 
SARS-CoV infection of macrophages induces chemokine but not IFN-(3 expression, 
indicating a dysregulation of antiviral response (22). Unlike mice, pigs are naturally 
susceptible to influenza and coronavirus (porcine respiratory coronavirus, PRCV), 
making the pig a useful model for investigating respiratory viral infection in the 
natural host. Moreover, unique differences in type I interferon responses between 
mouse and human have been described (23, 24) indicating the need for additional 
animal models to thoroughly understand type I interferon activation and regulation 
during viral infection. 
In this study, we analyzed the differential induction of the type I interferon by 
porcine AM and PM in response to polylC stimulation. We provide evidence that 
recognition and subsequent signaling following exposure of AM to dsRNA occurs 
through TLR3 whereas PM dsRNA response is activated by PKR. In addition, we 
show that AM regulation of the type I interferon response in pigs differs from that 
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previously described in mice, pointing to interesting species specific differences in 
regulation of antiviral immune responses. 
Materials and Methods 
Animals 
Conventionally reared, three to six week old pigs of either gender were maintained in 
isolation rooms at the National Animal Disease Center, Ames, IA according to facility 
animal care and use guidelines. Animals received 1 ml per day for three days of 
ceftiofur (Excenel; 50mg/ml) intramuscularly, beginning the day pigs were 
transported to the facility. Pigs were anesthetized with a combination of ketamine 
and xylazine given intramuscularly and subsequently euthanized with an overdose of 
pentobarbital given intravenously. Three to six animals per experiment were used 
and the number of replicates is noted in each figure. 
Macrophage isolation and culture 
The peritoneal cavity was washed three times with 250 ml 0.01 M PBS, pH 7.4 
(using a total volume of 750 ml) and approximately 500 ml was recovered. Lungs 
were lavaged with 300 ml of PBS and approximately 200 ml was recovered. 
Collected lavage was centrifuged at 400 x g for 15 minutes, cells washed once with 
PBS, and resuspended in supplemented medium [RPMI 1640, 5% swine sera, 5 mM 
HEPES, 1 mM L-glutamine, antibiotic-antimycotic, and 50 pg/ml gentamicin 
(Invitrogen Life Technologies, Carlsbad, CA). Cells were cultured in 150 x 15 mm 
Petri dishes for 2 h at 37°C. Non-adherent cells were removed and adherent 
macrophages released with a cell scraper, collected, washed once, and counted on 
a hemacytometer. Macrophages were seeded at 3.5 x 105 cells per well in a 48-well 
flat bottom plate with a final volume of 500 pi for cytokine studies (RT-PCR and 
bioassay) or at 2 x 106 cells per well in a 24-well plate with a final volume of 750 pi 
for western blot studies. Macrophages were stimulated for the indicated times with 
50 pg/ml polyriboinosinic:polyribocytidylic acid (polylC; Amersham Biosciences, 
Piscataway, NJ) and/or 200 U recombinant porcine IFN-a (rplFN-a; R&D Systems, 
Minneapolis, MN). Where indicated, cells were pretreated with 5 mM 2-aminopurine 
(2-AP; Sigma-Aldrich, Saint Louis, MO) for 45 min. Non-stimulated cells were 
included at each timepoint as controls. 
RNA preparation and real-time RT-PCR 
At each indicated timepoint, supernatant was collected and stored at -80 °C. 
Macrophages were lysed on the culture plate with RLT buffer, first step for RNA 
isolation (RNeasy Mini Isolation Kit, Qiagen). RNA was isolated, DNAse treated 
(RNase-free DNase, Qiagen), and cDNA was synthesized using random hexamers 
according to manufacturer's recommendations (Invitrogen Life Technologies, 
Carlsbad, CA). Sybr green based real-time PGR was carried out for various mRNA 
targets according to manufacturer's recommendations (SYBR green Master Mix, 
Applied Biosystems). Briefly, SYBR green master mix, primers, and template were 
mixed in a 20 pi reaction and cycled as follows: 95 °C for 15 minutes; 95 °C for 15 
seconds followed by 50 °C for 1 minute (45 cycles) and final dissociation step. All 
samples were run in duplicate. Levels of mRNA were calculated using the 2"AACt 
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method, which expresses mRNA in treated cells relative to non-stimulated cells after 
normalizing to (3-actin (25). Primers were generated using Primer Express, 
purchases from Integrated DNA Technologies (IDT; Coralville, IA) and used at a final 
concentration of 600 nM. Primer pair efficiency was confirmed using the method 
described by Livak and Schmittgen, 2001. PGR products were less than 100 base 
pairs in size and primers were as follows (5' to 3'): (B-actin-forward 
CTCCTTCCTGGGCATGGA, (3-actin-reverse CGCACTTCATGATCGAGTTGA; IFN-(3-forward 
TGCAACCACCACAATTCC, IFN-|3-reverse CTGAGAATGCCGAAGATCTG; IFN-a-forward 
GCCTCCTGCACCAGTTCTACA, IFN-a-reverse TGCATGACACAGGCTTCCA; Mx-1-forward 
TAGGCAATCAGCCATACG, Mx-1-reverse GTTGATGGTCTCCTGCTTAC; PKR-forward 
GAGAAGGTAGAGCGTGAAG, PKR-reverse CCAGCAACCGTAGTAGAG: RANTES-forward 
CTGCTTTGCCTACCTCTC, RANTES-reverse CTTGCTGCTGGTGTAGAA; TNF-a-forward 
CCACGTTGTAGCCAATGTC, TNF-a-reverse CT GGG AGTAG AT G AGGTACAG. Primers were 
generated using Primer Express, purchased from Integrated DNA Technologies 
(IDT, Coralville, IA), and primer pair efficiency confirmed using the method described 
by Livak and Schmittgen, 2001. 
Cell extracts and western blotting 
Macrophages were seeded at 2 x 106 cells per well in a 24-well plate with a final 
volume of 750 pi. At each indicated timepoint supernatant and cells were collected 
and spun at 300 x g for 5 minutes to pellet cells. Cytoplasmic and nuclear fractions 
were collected according to manufacturer's recommendations (NE-PER Extract, 
Pierce; Rockford, IL) and stored at -80°C. 
For western blot studies, 10 (jg of lysate was mixed with Laemmli sample buffer, 
heated at 95 °C for 5 minutes, and run into a 12% SDS-PAGE gel under denaturing 
and reducing conditions. Proteins were transferred to 0.45 pm nitrocellulose using 
tris-glycine transfer buffer (Invitrogen Life Technologies, Carlsbad, CA). After 
membranes were incubated in Superblock (Pierce, Rockford, IL) for 1 hour at room 
temperature, primary antibody was added and membranes incubated overnight at 4 
°C on an orbital shaker. Membranes were washed 6 times with PBS/0.05% tween-20 
and incubated with appropriate HRP-labeled secondary antibody for 2 h at room 
temperature. Membranes were washed as above and incubated for 2 minutes with 
substrate (SuperSignal PicoWest, Pierce). Signals were detected using radiographic 
film (X-Omat MR, Kodak; Rochester, NY). For reprobing, membranes were 
incubated for 20 minutes at 37 °C in stripping buffer (62.5mM Tris, 2% SDS, 2% 2-
mercaptoethanol) and then washed 4 times with PBS/0.05% tween-20. Antibodies 
used were: anti-STAT-1, anti-phospho-STAT-1 (Tyr701; pY-STAT-1), anti-PKR, anti-
phospho-PKR (Thr451; pPKR) (all from Cell Signaling Technology, Beverly, MA) and 
anti-(3-actin (Abeam Inc., Cambridge, MA). 
Interferon bioassay 
Levels of type I interferon secreted by stimulated AM and PM were measured as 
previously described (26, 27), with some modifications. Serial ten-fold dilutions of 
supernatant collected from non-stimulated and stimulated AM and PM were 
transferred to individual wells of a 96-well plate containing confluent PK-15 cells. 
After 1 h supernatant was removed and PK-15 cells were infected with green-
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fluorescent labeled vesicular stomatitis virus (GFP-VSV) at M0l=0.1. After 12 h, 
GFP was visualized by fluorescence microscopy. The presence of interferon in the 
culture supernatant was determined by decreased GFP signal indicating the ability 
to inhibit GFP-VSV replication. Samples from stimulated and non-stimulated cells 
were compared. As a control, the ability of porcine IFN-a to inhibit GFP-VSV 
replication was confirmed using a commercially available recombinant IFN-a (PBL 
Biomedical, Piscataway, NJ). 
Statistical analysis 
A student t-test was used to statistical analysis using Prism software. P-values < 
0.05 are noted by an asterisk in figures. 
RESULTS 
Type I interferon transcription is significantly greater in porcine AM than PM after 
polylC stimulation 
A strong type I interferon response to dsRNA is critical for the production of 
downstream antiviral mediators. TLR3 and PKR have been shown to recognize 
dsRNA and initiate the transcription of IFN-a/(3 (28). Accordingly, we investigated 
type I interferon gene transcription (IFN-f3 and IFN-a) following stimulation of AM and 
PM with polylC, a synthetic dsRNA molecule. In addition, recombinant porcine IFN-a 
(rplFN-a) was used to determine if exogenous IFN altered type I interferon 
responsiveness to polylC. Transcription of IFN-J3 and IFN-a after polylC stimulation 
was greater in AM than in PM at both the 12 and 24 hour timepoints (Fig. 1). The 
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addition of rplFN-a, in the presence or absence of polylC, did not significantly alter 
transcription of either type I interferon gene in AM or PM. In response to polylC, IFN-
(3 mRNA levels were highest at 12 h in both AM and PM, with mRNA levels 
decreasing by 24 h after stimulation. However, mRNA levels of IFN-(3 were nearly 
100-fold higher in AM in comparison to PM 12 h after polylC stimulation (Fig. 1A). By 
24 h after stimulation, PM IFN-(3 and IFN-a mRNA levels were similar to baseline, or 
that of mock treated cells. Yet, mRNA levels of both IFN-|3 and IFN-a remained 
elevated in AM at the 24-hour timepoint. Overall, AM responded to polylC 
stimulation with higher levels of type I interferon gene transcription (IFN-(B and IFN-
a) than PM and the addition of exogenous IFN-a did not alter the response. 
Transcription of interferon-dependent antiviral mediators, PKR and Mx, is greater in 
PM than AM after polylC or rplFN-a stimulation 
Type I interferon proteins (IFN-0 and IFN-a) function by inducing the expression of 
several antiviral mediators, such as Mx and PKR, within the host cell. These antiviral 
proteins are able to inhibit viral protein translation and viral assembly; and 
consequently, control virion production (29). Both macrophage populations 
responded to polylC with an increase in transcription of IFN-P and IFN-a (Fig. 1); 
therefore, we wanted to determine if this resulted in the subsequent transcription of 
interferon-dependent antiviral mediators, Mx and PKR. AM and PM transcription of 
Mx and PKR was examined after polylC stimulation. Cells were also stimulated with 
recombinant IFN-a to investigate transcription changes to exogenous type I 
interferon. 
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Both macrophage populations responded to polylC with the transcription of 
Mx and PKR, with the greatest transcriptional changes observed at 12 h (Fig. 2A). In 
response to polylC, AM exhibited a 2-fold increase in Mx mRNA and 9-fold increase 
in PKR mRNA levels at 12 h. However, by 24 h transcript level of both antiviral 
proteins were similar to baseline. PM response to polylC was stronger, with a 6-fold 
increase in Mx mRNA and 12-fold increase in PKR after 12 h of polylC stimulation. 
At 24 h Mx and PKR mRNA levels remained elevated, with at least a 5-fold increase 
over mock treated cells. At 24 h post-stimulation, PM had significantly higher mRNA 
levels of both Mx and PKR than AM after polylC stimulation. Overall, it is interesting 
to note that polylC stimulation of PM resulted in a significantly greater increase in Mx 
and PKR transcription (Fig. 2) than AM, even though AM showed a greater induction 
of IFN-P and IFN-a mRNA (Fig. 1 ) after polylC stimulation. 
The addition of rpIFN-a had a significant impact on Mx and PKR transcription 
in PM but not AM. Mx and PKR transcript levels in AM were similar regardless of the 
stimulus used (polylC, rplFN-a, or polylC + rplFN-a). Mx mRNA levels were nearly 
unchanged, while PKR mRNA levels were maximal at 12 h and declined to near 
baseline by 24 h. On the other hand, treatment of PM with rplFN-a did enhance 
transcription of Mx and PKR when compared to stimulation with polylC only. 
Compared to AM, Mx and PKR transcription was highest in PM treated with both 
polylC plus rplFN-a for 12 h (Fig. 2A), and these levels declined by 24 h (Fig. 2B). 
Overall, both Mx and PKR mRNA levels were significantly greater (p<0.05) in PM 
than AM at both 12 and 24 h when rplFN-a was used as a stimulus, with or without 
polylC (Fig.2). 
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AMphosphorylate STAT-1 in response to recombinant IFN-a indicating a functional 
type I interferon receptor (IFNAR) 
One plausible explanation for the low levels of Mx and PKR transcription after polylC 
or rplFN-a stimulation of AM would be the absence of or defective signaling via the 
type I interferon receptor, IFNAR. IFN-a or IFN-0 protein binding to IFNAR induces 
receptor rearrangement and subsequent autophosphorylation of Janus activated 
kinase (Jak). STAT-1, after phosphorylated by Jak, binds to phosphorylated STAT-2 
and translocates into the nucleus. A heterotrimer of STAT-1 : STAT-2:1RF-9 binds to 
DNA at the interferon-stimulated response element (ISRE), a conserved sequence in 
the promoter region of several genes, including Mx and PKR (30). Overall, STAT-1 
is critical for coordination of the IFN-a/p signal; therefore, we examined STAT-1 
phosphorylation and subsequent translocation into the nucleus of AM after polylC, 
rplFN-a, or polylC + rplFN-a stimulation. Phosphorylated STAT-1 (pY-STAT-1) was 
detected in both the cytoplasmic and nuclear fractions of AM lysates 2 h after rplFN-
a stimulation (Fig. 3). STAT-1 protein was detected in the cytoplasmic fraction of 
polylC treated AM, but pY-STAT-1 was not detected in the cytoplasm or nuclear 
fractions. If rplFN-a was added with polylC, pY-STAT-1 could be detected in the 
nuclear fraction. Overall, AM responded to rplFN-a with the phosphorylation and 
nuclear translocation of STAT-1 indicating functional IFNAR. 
AM produce bioactive IFN-a//3 in response to polylC stimulation 
After polylC stimulation, AM transcribed both IFN-(3 and IFN-a mRNA; however, the 
interferon-stimulated genes (ISG) Mx and PKR typically induced by IFN-a/p protein, 
did not increase as significantly as that observed in PM. AM did respond to the 
addition of rplFN-a with the nuclear translocation of pY-STAT-1, indicating an intact 
receptor and signaling machinery (Fig. 3). To determine if the IFN-(3 and IFN-a 
mRNA detected in AM after polylC treatment was translated into biologically active 
protein, a type I interferon bioassay was utilized. AM and PM were exposed to 
polylC for 2 hours before the supernatant was replaced; cells were washed once, 
and subsequently replenished with fresh medium to ensure that polylC did not 
remain in the supernatant. After 12 or 24 h, supernatant was collected and assayed 
for bioactive type I interferon. Fig. 4 shows that supernatants from polylC stimulated, 
but not mock treated, AM and PM contained type I interferon protein. Vesicular 
stomatitis virus (VSV) replication was greatest in mock treated cells; however, AM 
supernatants inhibited VSV replication to the greatest extent, indicating presence of 
high levels of bioactive type I interferon. PM supernatant inhibited VSV replication as 
well, but not to same extent as AM. Taken together, AM likely produce more 
bioactive type I interferon after polylC stimulation than PM (Fig. 3), which is similar to 
transcriptional observations (Fig 1). Overall, the lack of Mx and PKR transcription 
after polylC stimulation in AM is not due a lack of type I interferon protein production, 
as AM secreted bioactive type I interferon after polylC stimulation. Interestingly, 
these results differ from a previous study in mice showing that murine AM transcribe 
IFN-(3 after polylC stimulation, but do not secrete IFN-(B protein (31). 
2-aminopurine inhibits polylC induced transcription of type I interferon and 
interferon-stimulated genes (ISG) in PM but not AM 
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As shown above, IFN-|3 and IFN-a transcription after polylC stimulation was greater 
in AM than PM, regardless of the addition of exogenous IFN-a (Fig. 1 ). In order to 
investigate the differential mechanism by which IFN-(3 and IFN-a mRNA transcription 
is activated in AM and PM, 2-aminopurine (2-AP) was used to block PKR activation. 
PKR, like TLR3, is a cellular sensor for dsRNA and is able to induce IFN-|3 
transcription via the NFKB pathway (11, 12). Therefore, PKR is not only an effector 
molecule in the antiviral response, but is also capable of initiating the type I 
interferon system (15). 2-AP has been shown to act as a serine/threonine kinase 
inhibitor and to specifically block the activation of PKR (19). 
Therefore, in order to determine whether activation of PKR may play a role in 
IFN-P and IFN-a transcription, macrophages were treated with 5 mM 2-AP for 45 
minutes prior to stimulation with polylC, rplFN-a, or polylC plus IFN-a. Fig. 5 shows 
that AM levels of IFN-P and IFN-a mRNA transcript after polylC treatment did not 
change significantly when pretreated with 2-AP. in contrast, IFN-p and IFN-a mRNA 
levels were significantly lower in PM pretreated with 2-AP after polylC stimulation. In 
addition, Mx and PKR mRNA levels were significantly lower in 2-AP pretreated PM. 
Mx and PKR transcription in AM was not induced in response to polylC, as 
previously shown (Fig.2) and this did not change with 2-AP pretreatment (Fig. 5). 
Overall, 2-AP was able to inhibit activation of the type I interferon response in PM 
after polylC stimulation, but not AM, indicating a differential mechanism of activation 
between these two macrophage populations. 
Addition ofrplFN-a to PM and AM pretreated with 2-AP recovers Mx and PKR 
transcription 
Pretreatment of PM with 2-AP blocked the transcription of both IFN-P and IFN-a 
mRNA as well as downstream ISG, Mx and PKR (Fig. 1 and Fig. 2) in response to 
polylC. We sought to determine if the loss of Mx and PKR transcription in polylC 
stimulated PM pretreated with 2-AP resulted from low levels of IFN-a/p. Thus, 2-AP 
treated PM were exposed to rplFN-a to determine if exogenous IFN-a could recover 
Mx and PKR transcription. Indeed, Fig. 6A shows that transcription of Mx and PKR 
was recovered in PM pretreated with 2-AP prior to the addition of rplFN-a. Recovery 
of Mx and PKR mRNA expression was also detected in PM pretreated with 2-AP 
prior to polylC plus rplFN-a stimulation, although Mx mRNA levels were slightly 
lower when polylC was present (Fig. 6B). The addition of rpIFN-a to polylC 
stimulated PM pretreated with 2-AP did not alter IFN-(3 or IFN-a transcription from 
that observed for cells not pretreated with 2-AP (data not shown). Overall, data 
indicate that the lack of Mx and PKR transcription in polylC stimulated PM pretreated 
with 2-AP was the result of 2-AP inhibiting the production of IFN-a and IFN-(3. 
Although AM produced bioactive type I interferon after polylC stimulation (Fig. 
4), Mx and PKR transcription did not increase. Furthermore, the addition of 
exogenous IFN-a to AM did not induce Mx or PKR transcription (Fig. 2). 
Interestingly, AM transcription of Mx and PKR was elevated 24 h after rp IFN-a 
stimulation if cells were pretreated with 2-AP (Fig. 6A). 2-AP pretreatment of rp IFN-a 
stimulated AM did not significantly alter IFN-(3 or IFN-a transcription (data not 
shown); consequently, the increase in Mx and PKR transcription with 2-AP 
pretreatment is not due to increased production of IFN-(3 or IFN-a. The effects of 2-
AP on rplFN-a induced transcription in AM were most evident with Mx mRNA level, 
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which was nearly 4-times higher in 2-AP pretreated than untreated cells (Fig. 6A). 
However, if polylC was used in combination with rplFN-a, 2-AP pretreatment did not 
affect Mx mRNA levels (Fig. 6B). Taken together, induction of Mx and PKR gene 
transcription in AM only occurred in response to rp IFN-a subsequent to 2-AP 
pretreatment. 
PKR protein levels and phosphorylation increase in polylC treated PM but not AM 
IFN-a and IFN-P transcription induced after polylC stimulation was inhibited by 2-AP 
pretreatment of PM, but not AM, (Fig. 5), suggesting that PKR is likely involved in 
activation of the type I interferon response in PM but not AM. In order to determine if 
PKR activation was involved in differential response of AM and PM to polylC 
stimulation, the phosphorylation of PKR after polylC stimulation was examined (Fig. 
7). PKR protein levels were increased in polylC stimulated PM but not AM, and 
phosphorylated PKR (p-PKR) was detected only in PM. Overall, PKR protein by PM 
was upregulated and phosphorylated following stimulation with polylC; however, 
PKR changes were not observed in stimulated AM. 
PolylC induces the transcription of immediate-early genes, TNF-a and RANTES, in 
AM but not PM 
An important function of macrophages is early production of cytokines and 
chemokines after PAMP recognition, for recruitment of effector cells to sites of 
infection. TLR3 recognizes dsRNA and signals for the transcription of IFN-a/p as 
well as immediate-early genes, such as TNF-a AND RANTES, via the MyDÔÔ-
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dependent and independent pathway, respectively (32). TNF-a mRNA transcription 
is controlled by MyD88-dependent activation of the NFKB signaling pathway (4). 
Conversely, RANTES transcription is MyD88-independent and relies on TLR3-TRIF-
IRF3 pathway (8). To determine if the observed differences in the type I interferon 
activation of AM and PM extended to signaling pathways controlling immediate-early 
genes, dsRNA induced transcription of TNF-a and RANTES was examined. TNF-a 
and RANTES mRNA levels were significantly greater in AM than PM after polylC 
stimulation (Fig. 8A). Induction of both TNF-a and RANTES in AM was dependent 
on the presence of polylC, as rp IFN-a did not alter transcription of either gene. 2-AP 
pretreatment of AM did not inhibit the production of TNF-a or RANTES in response 
to polylC, suggesting that PKR is not involved in TNF-a or RANTES induction (Fig. 
8B). Overall, these data indicate that AM likely recognized and responded to dsRNA 
via TLR3 and PM utilized PKR for dsRNA induced responses. 
DISCUSSION 
The current study is the first to investigate the type I interferon activation mechanism 
in porcine macrophage subsets and results indicate porcine AM regulate type I 
interferon responses differently than murine macrophages when stimulated with 
polylC (31, 33). Although porcine AM and PM produced bioactive type I interferon 
after polylC stimulation (Figs.1 and 4), the AM response was unique to that 
observed for PM, as transcription of ISGs Mx and PKR occurred in PM but not AM 
(Fig. 2). Pretreatment of PM with the PKR inhibitor, 2-AP, abolished transcription of 
both IFN-P and IFN-a after polylC stimulation, but did not alter AM IFN-a/p 
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transcription (Fig. 5). Further significant differences between AM and PM response 
to polylC were observed in transcription of MyD88-dependent and independent 
genes, TNF-a and RANTES, respectively (Fig. 6). Taken together, data from this 
study illustrates distinct activation mechanisms between macrophage populations in 
the pig, as well as unique species-specific differences in controlling AM type I 
interferon responsiveness to dsRNA. 
One important finding presented in this study is the differential mechanism by 
which different species regulate AM responsiveness to dsRNA. The lung is a 
particularly vulnerable organ because of constant antigen exposure during 
respiration. Pulmonary immune responses must be able to eliminate or control 
infectious agents, but also limited in magnititude to avoid uncontrolled inflammation 
that would compromise pulmonary function. A recent paper investigating murine AM 
responses to dsRNA demonstrated that IFN-(3 mRNA is transcribed but not secreted 
after polylC stimulation (31). Thus, the murine AM type I interferon response after 
dsRNA stimulation is considerably different from porcine AM response, as porcine 
AM secreted bioactive type I interferon after polylC stimulation (Fig. 4). Nonetheless, 
porcine AM also appeared to regulate the type I interferon response, but instead of 
limiting IFN-a/p production (31), porcine AM may control transcription of ISGs (e.g. 
Mx and PKR) in response to IFN-a/(3. IFN-a/|3 protein binds IFNAR and receptor 
associated kinases, Jak1 and Tyk2, induce phosphorylation of the transcription 
factors STAT-1 and STAT-2. Once phosphorylated, STAT-1 (pY-STAT-1) can form a 
homodimer or a heterodimer with STAT-2 (30) and bind to specific DNA promoter 
sequences to promote the transcription of different genes (Katze et al., 2002). STAT-
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1 homodimers bind to the IFN-y-activated (GAS) element, whereas STAT-1 :STAT-2 
heterodimer (with IRF-9) binds to DNA at the interferon-stimulated response element 
(ISRE) (30). pY-STAT-1 was detected in porcine AM stimulated with rplFN-a for 2 h; 
however, later timepoints after rplFN-a were not tested. PolylC stimulation of AM did 
not induce pY-STAT-1 and detection of pY-STAT-1 was reduced if AM were 
stimulated with both polylC plus rp IFN-a (Fig. 3), suggesting the activation of an 
inhibitory response with polylC stimulation. Suppressors of cytokine signaling 
(SOCS) are a family of regulatory proteins (SOCS 1-9) that can inhibit cytokine 
signaling transduction pathways, including STAT-1 dependent signaling (Yoshimura 
et al., 2004, Alexander, 2002). SOCS proteins are upregulated by cytokines (e.g. 
IFN-a/0) and by TLR agonists (34). SOCS-1 and 3 have been shown to inhibit IFN-
induced expression of antiviral proteins including Mx (35). It is possible that porcine 
AM constitutive^ express SOCS proteins, thus, regulating responsiveness to IFN-
a/(3. In addition, polylC signaling via TLR3 in AM may enhance the production of 
inhibitory proteins, subsequently inhibiting the transcription of ISG to polylC induced 
IFN-a/|3. Taken together, both murine and porcine AM have mechanisms for 
controlling type I interferon responses. 
Compared to PM, AM did not significantly increase transcription of ISGs, Mx 
and PKR, after stimulation with polylC or rplFN-a. Only when AM were pretreated 
with 2-AP did rplFN-a exposure result in enhanced expression of Mx and PKR. 
Interestingly, polylC could inhibit the effects of 2-AP on AM, as Mx and PKR 
transcription did not change significantly in 2-AP pretreated AM if polylC and rplFN-a 
were used as a stimulus (Fig 6). It has recently been demonstrated that NFKB 
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negatively regulates type I interferon induced gene expression, presumably by 
blocking the binding sites of various interferon stimulated gene (ISG) promoters. 
NFKB (p50/p65) knockout cells inhibited influenza virus replication to a greater 
extent than wild-type cells indicating that NFKB inhibits several functionally important 
type I interferon activities (36). Evidence suggests that IFN-a/p activates NFKB 
transcription factors in a serine/threonine kinase-dependent manner (37). This may 
explain why Mx and PKR transcription occurred in rplFN-a stimulated AM only when 
pretreated with the serine/threonine kinase, 2-AP. Thus, 2-AP inhibited a 
serine/threonine kinase involved in NF-KB activation, and consequently, removed the 
NF-KB inhibition of ISG promoter, resulting in enhanced Mx and PKR transcription. It 
is possible that 2-AP could not fully inhibit the unidentified kinase when polylC was 
used with rp IFN-a as a stimulus. Moreover, the unidentified serine/threonine kinase 
activating NF-KB and subsequently blocking the ISG promoters may be a regulatory 
mechanism used by AM for controlling type I interferon responsiveness. Further 
studies are warranted to determine the mechanism involved in regulating AM type I 
interferon responses and identifying proteins involved. 
In addition to showing species-specific differences in MO regulation of type I 
interferon responses to dsRNA, the current study highlights that MO populations 
differentially respond to the same stimuli. Several pieces of data in the current study 
strongly suggest that porcine AM and PM recognition of dsRNA occurred through 
different dsRNA cellular sensors. The induction of type I interferon and RANTES 
gene transcription, which occurred in porcine AM, indicates the need for IRF-3 
activation (8, 9). IRF-3 is activated by TRIF, an adaptor protein of TLR3 (10). 
87 
Although dsRNA induced IFN-a/(3 transcription in PM, RANTES transcription did not 
change in polylC stimulated PM, indicating TLR-TRIF-IRF-3 is not likely involved in 
PM response to polylC. MyD88 another adaptor protein of TLR3, has been shown to 
induce NF-KB activation for the subsequent transcription of IFN-P and TNF-a (4, 38). 
As PM did not show enhanced TNF-a transcription in response to polylC, the TLR3-
MyD88-NF-KB signaling pathway was not likely involved in PM response to polylC. 
PKR can induce transcription of type I interferon after activation by dsRNA, and PKR 
is sensitive to the chemical compound 2-AP. PM, but not AM, IFN-a/p transcription 
after polylC stimulation was sensitive to the effects of 2-AP. Taken together, TLR3 
was likely involved in dsRNA-induced response elicited by AM, whereas PKR was 
involved in PM response. 
Collectively, the current study shows that porcine AM and PM recognize the 
viral PAMP, dsRNA, through different cellular PRR, which results in differential 
transcription of IFN-a/p and the proinflammatory cytokines, TNF-a and RANTES. 
Furthermore, results from the current study and other published reports indicate an 
interesting species-specific mechanism for regulating type I interferon 
responsiveness in AM. Regulation of the type I interferon response is likely specific 
to AM, as the lung requires judicious control of immune responses to prevent 
erroneous, uncontrolled activation. The recent emergence of pathogenic influenza 
and critical role of AM for viral clearance exemplifies the need for understanding 
mechanisms of immune regulation in AM. Furthermore, pigs provide a useful model 
for investigating respiratory disease, as they are naturally susceptible to several 
respiratory pathogens, including influenza virus. 
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FIGURE 1. Type I interferon transcription in AM's and PM's. A, 12- and B, 
24-hours after stimulation with polylC, rp IFN-a, or polylC plus rplFN-a. Data 
is expressed as mean ± SEM of four animals. Data is representative of three 
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FIGURE 2. Transcription of interferon stimulated genes (ISG) Mx and PKR in 
AM and PM A, 12- and B, 24-hours after stimulation with polylC, rplFN-a, or 
polylC plus rplFN-a. Data is expressed as mean ± SEM of four animals. Data 
is representative of three independent experiments. 
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FIGURE 3. Phosphorylation of STAT-1 (pY-STAT-1) after stimulation 
with rplFN-a in AM. Cells were stimulated for 2 hours, cytoplasmic (C) 
and nuclear (N) extracts collected, and subsequently probed for STAT-1 
and pY-STAT-1. Whole cell lysate from Hela cells stimulated with 
recombinant IFN-a were was used as a positive control (+). Data is 
representative of three animals and two separate experiments. 
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FIGURE 4. Production of bioactive type I interferon by AM and PM at A, 12-
and B, 24-hours after stimulation with polylC. Supernatants collected from 
stimulated macrophages were incubated on PK-15 cells for 1 hour. GFP-VSV 
was added to each well and fluorescence measured after 12 hours. Presence 
of bioactive IFN inhibits GFP-VSV replication, indicated by a low level of GFP 
fluorescence. 
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ABSTRACT 
Porcine reproductive and respiratory syndrome virus (PRRSV) continues to 
be an economically important infectious disease of swine and mechanisms 
governing activation of the innate immune response remain to be elucidated. 
Virulence differences observed between PRRSV isolates have been attributed to 
replication ability in vivo, not immunogenic differences. To simultaneously 
investigate activation of the type I interferon response and the affects of viral 
replication on innate immunity, the current study utilized a single isolate of PRRSV at 
two different doses. Acute phase changes in body temperature, viral load, antibody 
levels, cellular infiltration into pulmonary tissue, and the interferon response were 
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measured in animals receiving either a low (102 CCID50) or high (106 CCID50) dose 
inoculum. Initial PRRSV dose did not correlate to sera levels of PRRSV vRNA or 
antibody during the acute infection (day 2 to 12 PI), but did have an effect on the 
early immune response and mortality. Type I interferon responses, measured by 
transcriptional changes in IFN-(3, IFN-a, Mx, and PKR, were uniquely different when 
assessed relative to viral dose or to cell type (AM or PBMC) on day 3 PI. Serological 
IFN-y levels correlated to the viral load in sera samples, and differences between 
challenge doses were demonstratable by day 19 PI. Overall, pigs inoculated with a 
low or high dose of PRRSV did not display significant differences in circulating vRNA 
load or type I interferon response during the acute stage of infection; however, 
eventual clearance and IFN-y levels in the sera were dependent upon initial viral 
dose. Animals receiving high dose inoculum were viremic longer and eventually 
succumbed to respiratory disease. IFN-y may play a role in PRRSV pathogenesis, 
as serum levels increased significantly in pigs challenged with high dose of PRRSV. 
INTRODUCTION 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a single-
stranded RNA virus of the Arteriviridae family and is the causative agent for one of 
the most important diseases of swine worldwide. The pathogenesis of PRRSV 
consists of an acute stage of disease, characterized by viremia that can last up to a 
month, followed by a persistent stage (33, 42), in which virus can be isolated from 
lymphoid tissue for months following exposure (12, 16). Although the mechanism for 
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PRRSV persistence is unknown, it is suggested that PRRSV does not enter a latent 
stage, but instead, continuous viral replication ocurrs (2). 
Since PRRSV was described in the late 1990s, various isolates have been 
collected and used experimentally (22, 30). Certain isolates have been described as 
being more virulent than others, which is often associated with clinical 
manifestations in infected pigs, such as severe pneumonia or reproductive failure 
(20, 30). However, the mechanism by which a particular strain or isolate manifests a 
particular phenotype is unknown (20). Virulence differences between individual 
isolates have been attributed to in vivo replication (22) and/or PRRSV tissue 
distribution (21). PRRSV can often be attenuated by continuous passage in cell 
culture, and when subsequently used in vivo, cell-culture attenuated PRRSV does 
not replicate to as high a titer (when measured in the sera) nor does viremia last as 
long when compared to pigs infected with the parent strain. Overall, is has been 
postulated that in vivo replication of a particular isolate is a key determinant of 
virulence (22). 
Attenuated virus, derived from cell culture passage, is genotypically different 
than the parent strain from which it was derived (19). Consequently, not only will the 
ability of the virus to replicate in vivo change, but epitopes involved in immune 
recognition may be different as well. Viral genotypic changes resulting either from 
cell culture passage or evolution in the host may alter activation of the host immune 
response. For example, it was recently shown that alveolar macrophages differ in 
type I interferon production when exposed to different PRRSV isolates in vitro (25). 
Although it is likely that the ability of a particular PRRSV to replicate to a greater 
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quantity in vivo does play a role in virulence, studies comparing the immune 
response in pigs infected with either the parent or attenuated strain may be 
misleading because factors other than replication ability and viral load may be 
involved in controlling pathogenicity, such as the host immune response. Thus, we 
have investigated the immune response of pigs infected with differing doses of the 
same PRRSV isolate. This experimental design eliminated genetic differences that 
might arise between isolates and replication efficiency, but focused on the effects of 
viral load relative to pathogenicity. 
The innate immune response to a virus begins almost immediately with 
recognition of conserved viral epitopes, such as dsRNA, by host cells. Type I 
interferon (IFN-a/(3) plays a significant role in the innate antiviral immune response 
by stimulating the production of antiviral mediators, such as Mx (myxovirus resistant; 
IFN-inducible GTPase) and PKR (double-stranded RNA dependent protein kinase) 
(3, 4, 32), which inhibit viral replication (23). In addition, IFN-a/|3 plays a role in the 
adaptive immune response by stimulating dendritic cell maturation (18) and act as a 
survival factor for activated T-cells (8, 27). 
IFN-a has been shown to inhibit PRRSV replication, both in vitro (1) and in 
vivo (9, 10). However, little IFN-a is produced during PRRSV infection (1, 9, 39), 
which is consistent with the observed delay in the adaptive immune response to 
PRRSV (33). It has been shown that IFN-a produced in response to another virus, 
such as porcine circovirus 2 (PCV2) or porcine respiratory coronavirus (PRCV), 
inhibited a coincident or subsequent PRRSV infection (9, 10). Overall, these data 
indicate IFN-a production significantly affects the ability of PRRSV to infect a 
susceptible animal. Defining factors involved in the attenuated IFN-a/(3 response 
following exposure to PRRSV may allow for the elucidation of efficacious vaccine 
regimen or therapeutic targets. 
Taken together, we hypothesize that the initial exposure dose of PRRSV will 
have an impact on clinical signs, viral load and resultant innate immune response(s). 
To address this question, but eliminate genotypic differences between parent and 
cell culture passaged strains, we investigated the acute immune response in pigs 
infected with either a low (102 CCID50) or high (106 CCID50) dose of a virulent 
PRRSV isolate (SDSU 73) that is capable of replicating to high titers in vivo (22). 
MATERIALS AND METHODS 
Animals and housing. Conventionally reared, 3 to 6 week old, mixed sex 
pigs from a herd free of PRRSV were maintained in isolation rooms at the National 
Animal Disease Center (NADC), Ames, IA according to facility animal care and use 
guidelines. Animals received 1 ml per day for three days of ceftiofur (Excenel; 
50mg/ml) intramuscularly, with the first dose given the day pigs were transported to 
the facility. Pigs were randomly assigned to treatment groups and rectal 
temperatures were recorded daily. All animal related procedures were approved by 
the IACUC at the NADC. 
Experimental design and virus. Two separate, identical experiments were 
performed, with the exception of additional pigs used during the repeat experiment. 
Twenty-four pigs were separated into different 3 treatment groups. Six pigs were 
used as controls, receiving 4 ml of cell culture medium; 9 received a low dose 
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inoculum (102 CCID50 in 4 ml, 2 ml per nostril), and 9 pigs received a high dose 
inoculum (106 CCID50 in 4ml, 2 ml per nostril). A total of 8 pigs (2 controls, 3 low 
dose, and 3 high dose) were euthanized on days 1, 3, and 5 PI. The second 
experiment was a replicate of the first, with 3 additional pigs in each treatment group 
used for sampling beyond day 5. The SDSU 73 PRRSV strain, initially isolated from 
a severe case of reproductive disease on a farm in Iowa in 1996, was used after two 
passages on MARC-145 cells. 
Sample collection and cell isolation. Blood was collected by superior vena 
cava venipuncture into clotting or heparin CPT Vacutainer tubes. For serum 
collection, tubes were centrifuged at 600 x g for 15 minutes at 4°C. Serum was 
aliquoted and stored at -80°C until use. For peripheral blood mononuclear cell 
isolation, heparinized CPT vacutainer tubes were centrifuged at 800 x g for 15 
minutes. The buffy coat was collected and cells washed once with 0.01 M PBS, pH 
7.4. At necropsy, bronchial-alveolar lavage (BAL) was collected by lavaging the 
lungs with PBS. An aliquot was immediately frozen at -80°C for viral isolation at a 
later time. 
Lung lavage was centrifuged at 500 x g for 15 minutes and half of the isolated 
cells were cultured for 2 hours at 37°C in a Petri dish in supplemented medium 
[RPMI 1640 (Invitrogen), 5% swine sera, 5 mM HEPES, 1 mM L-glutamine 
(Invitrogen), 1X antibiotic-antimycotic (Invitrogen), and 50 |jg/ml gentamicin]. Non­
adherent cells were removed; adherent alveolar macrophages were released using 
a cell scraper and collected by centrifugation. Tracheal-bronchial lymph nodes 
(TBLN) were removed, homogenized by passing through a sterile mesh screen with 
a glass pestle, and the single-cell suspension was washed with PBS and passed 
over a 70-|jm screen filter. An aliquot of all isolated cells were frozen at -80°C in 500 
pi PBS for virus isolation and RLT buffer (Qiagen, Mini RNeasy Isolation kit), for later 
RNA extraction. 
Sections from the right cranial and right caudal lung lobes were taken for 
microscopic examination. The tissues were fixed in 10% neutral buffered formalin 
for 24 hours and then placed in 90% ethanol. All sections were routinely processed 
and embedded in paraffin, sectioned, and stained with hematoxylin and eosin. 
Evaluation of viral load and antibody levels. A real-time PGR assay for 
PRRSV (J. Richt et al, unpublished data) was used to quantify viral RNA in the 
serum of pigs. Viral RNA was isolated from the individual sera samples using Viral 
RNA Isolation Kit (Qiagen). A one-step RT-PCR kit (Qiagen) was used according to 
manufacturer's recommendations with a few modifications. Each reaction contained 
the following: 8 pi of sample or standard, 0.4 pmol each of forward and reverse 
primer, 0.1 pM probe, 400pM each dNTP, 5 pg non-acetylated bovine serum 
albumin (Sigma), 5.5 mM MgCI2, 2.5 U RNase inhibitor (Invitrogen), one-step PGR 
buffer (5 pi, Qiagen kit), and enzyme mix (1 pi, Qiagen kit). Reactions were 
performed in a final volume of 25 pi and cycling parameters set as follows: 50 °C for 
30 minutes; 95 ° for 15 minutes; 45 cycles of 94 °C for 15 seconds followed by 60 °C 
for one minute with fluorescence detected during this final step. Primers and probe 
were generated using Primer Express, purchased from Integrated DNA 
Technologies (IDT) and the generated PGR product was 105 base pairs. Primers 
and probe sequences (5' to 3') are as follows: PRRSV-forward 
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TCAGCTGTGCCAGATGCTGG, PRRSV-reverse AAATGGGGCTTCTCCGGGTTTT, PRRSV-
probe FAM-TCCCGGTCCCTTGCCTCTGGA-Blackhole Quencher. 
In vitro transcribed ORF-7 gene RNA was used to set up a standard curve of vRNA 
copy number for vRNA quantification. The PRRSV ORF-7 gene was cloned into 
pCRII-TOPO (Invitrogen) and transcribed using the Ribomax™ Large Scale RNA 
Production kit (Promega). Transcribed RNA (cRNA) was DNase-treated (Ambion), 
quantified by spectrophotometry, and cRNA concentration was converted to 
molecular number (17). Tenfold serial dilutions of cRNA were used for generating a 
standard curve and corresponded to 2.5 x 102 to 2.5 x 106 copy numbers. Results 
were converted to log™ values for graphing and statistical analysis. 
Virus isolation was performed using MARC-145 cells (a monkey kidney cell 
line permissive to PRRSV) for serum, peripheral blood mononuclear cells, bronchial-
alveolar lavage, and tracheal-bronchial lymph nodes. Cells frozen in PBS were 
thawed, re-frozen once, thawed and 100 pi plated on MARC-145 cells. After 2 hours 
media containing the sample was removed and replaced with fresh media. Each well 
was examined for cytopathic effect (CPE) and assessed as positive or negative after 
one week of culture. ELISA S/P ratios were generated on collected serum samples 
by performing the HerdCheck® PRRS ELISA 2XR according to manufacturer's 
instructions. 
Cytokine gene expression. RNA was isolated from cells (Qiagen RNeasy 
Mini kit), cDNA was synthesized with random primers (Invitrogen), and SYBR green 
based real-time PCR carried out for various m RNA targets according to 
manufacturer's recommendations (SYBR Green Master Mix, Applied Biosystems). 
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Briefly, cDNA, SYBR green master mix and primers (final concentration 600nM) 
were mixed in a 20 pi reaction and cycled as follows: 95 °C for 15 minutes, 95 °C for 
15 seconds followed by 50 °C for 1 minute (45 cycles) and a final dissociation step. 
All samples were run in duplicate. Levels of mRNA were calculated using the 2"MCt 
method, which expresses mRNA in treated cells relative to mock infected cells after 
normalizing to |3-actin (26). PGR products were less than 100 base pairs in size and 
primers were as follows (5' to 3'): |3-actin-forward CTCCTTCCTGGGCATGGA, (3-actin-
reverse CGCACTTCATGATCGAGTTGA; IFN-|3-forward TGCAACCACCACAATTCC, IFN-0-
reverse CTGAGAATGCCGAAGATCTG; IFN-a-forward GCCTCCTGCACCAGTTCTACA, IFN-
a-reverse TGCATGACACAGGCTTCCA; Mx-1-forward TAGGCAATCAGCCATACG, MX-1-
reverse GTTGATGGTCTCCTGCTTAC; PKR-forward GAGAAGGTAGAGCGTGAAG, PKR-
reverse CCAGCAACCGTAGTAGAG. Primers were generated using Primer Express, 
purchased from Integrated DNA Technologies (IDT), and primer pair efficiency 
confirmed using the method described by Livak and Schmittgen, 2001. 
Inteferon-Y ELISA. A commercial kit (Biosource) for measuring porcine IFN-y 
was used according to manufacturer's recommendations to quantify levels in the 
serum from samples collected at various days PI. Samples were run in duplicate 
and amount of IFN-y (pg/ml) were calculated with reference to a recombinant 
porcine IFN-y standard supplied in the kit. 
RESULTS 
Pigs exposed to high dose of PRRSV exhibit higher body temperatures 
than pigs receiving low dose. In order to determine if pigs inoculated with different 
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doses of PRRS virus exhibited variations in early clinical signs of disease, rectal 
temperatures were recorded daily through 5 days post infection (PI). Figure 1 shows 
that pigs receiving the high inoculum averaged a higher body temperature than 
animals receiving the low dose inoculum. The average body temperature for high 
dose pigs increased by day 2 PI, and continued to gradually increase through day 5. 
It was 4 days PI before pigs receiving the low dose showed a significant elevation in 
body temperature when compared to control animals. By day 5, the high dose group 
had an average body temperature of 105.3 °F, which was significantly higher 
(p<0.05) than the low dose average of 103 °F. Overall, the pigs inoculated with the 
high dose exhibited a higher body temperature than those receiving the low dose of 
PRRSV during the early stage of disease, indicating that pigs initially exposed to 
different doses of PRRSV demonstrate differences in clinical signs. 
PRRSV isolation from nasal swab, lung lavage, and tracheal-bronhcial 
lymph node is similar between low and high dose groups after 1 day PI. In 
order to determine if the dose of the challenge inoculum results in differential virus 
distribution throughout the body, various tissues were sampled for viral isolation. On 
day 1 PI there were significant differences between the number of animals positive 
for virus based upon analysis of nasal swabs, lung lavages, and tracheal-bronchial 
lymph node (TBLN) samples, but by day 3 PI, there was no discernable difference 
between challenge groups (Table 1). By day 3 PI, all animals, regardless of 
challenge dose (low or high dose) were positive for virus in all three tissues 
sampled. Virus was also isolated from the lung lavage and TBLN of all the animals 
receiving the high dose inoculum at day 1 PI, and from two of the three nasal swab 
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samples. On the contrary, at 1 day PI, virus was not isolated from any of the nasal 
swab samples collected from pigs receiving the low dose inoculum; and, virus was 
only isolated from the lung lavage and TBLN of one animal receiving the low dose 
inoculum. Overall, this data indicates PRRSV dissemination occurred more rapidly in 
pigs receiving the 10s CCID50 inoculum than pigs inoculated with 102 CCID50. 
Nonetheless, by day 3 PI, viral distribution was the same regardless of inoculum 
dose (table 1). 
Serum viral load during acute infection is independent of initial viral 
dose. PRRSV primarily infects and replicates in alveolar macrophages (AM) (15, 
37), but typically goes systemic, resulting in a viremia that can last up to a month. 
Viral load is often used as a measure of disease severity, and virus replication ability 
has been correlated to strain-specific pathogenicity. In order to determine if the viral 
dose in the challenge inoculum of PRRS virus results in detectable differences in 
viral load, the amount of viral RNA (vRNA) in the sera was measured at various days 
PI. All of the pigs receiving the high dose inoculum were serologically positive for 
viable PRRSV within 1 day PI (Table 2). The low dose challenged pigs remained 
serologically negative for PRRSV, tested both by virus isolation (table 2) and real­
time PGR (fig. 2A), at 1 day PI. Suprisingly, by day 2 PI, no discernable difference in 
virus isolation or vRNA load could be made between animals receiving the high or 
low dose of the virus (table 2 and fig. 2A). In fact, virus could be isolated from serum 
samples collected from four of the six pigs receiving the low dose inoculum. In 
addition, there was no statistical difference in serum vRNA load between treatment 
groups at this timepoint. 
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The inability to distinguish between pigs initially exposed to a low or high dose 
inoculum based on serum viremia continued through 5 days PI. Although the 
average vRNA load was greater in the high dose pigs, the differences were not 
statistically significant (p>0.05). We continued to measure serum vRNA load after 5 
days to determine if the clearance kinetics of both groups was similar. Still, at days 9 
and 12 PI, the vRNA loads were similar between the two groups. However, at day 19 
there was a striking and significant difference in the vRNA load and virus isolation 
values between the 2 groups of animals (table 2 and fig. 2A). Although minimal 
amounts of vRNA were detected in the sera of pigs in the low dose group, viable 
virus was not isolated from any of the animals (table 2). However, viable virus was 
isolated from 2 of the 3 high dose pigs and vRNA levels were significantly higher 
than the low dose group. Overall, this data shows that pigs infected with a low dose 
inoculum cannot be differentiated from animals receiving a high dose inoculum 
based on serum viral load during the acute stages of infection. However, sometime 
between 2- and 3-weeks PI, it appeared that animals inoculated with 102 CCID50 
began controlling the viral infection (replication), but pigs receiving the 106 CCID50 
inoculum did not. 
PRRSV was isolated from peripheral blood mononuclear cells of pigs 
infected with a low or high dose of PRRSV. In order to investigate the differences 
in viral load and distribution in pigs inoculated with either a low or high dose of 
PRRSV, virus isolation from peripheral blood mononuclear cells (PBMC) was 
examined through 19 days PI. The isolation of PRRSV from PBMCs was similar to 
the isolation results for serum between days 2 and 12 PI. PRRSV was not detected 
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in the serum of any of the low dose animals tested on day 1, but virus was isolated 
from one of the corresponding PBMC samples. All of the pigs receiving the high 
dose inoculum were serologically positive for PRRSV by day 1 and virus was 
isolated from five of the six PBMC samples at this same time point (table 2). By 2 
days PI, there was no discernable difference in PRRSV tissue distribution between 
the low and high dose groups. Although not all of the serum or PBMC samples 
collected on day 2 PI were PRRSV-positive, the ratio of positive to negative in serum 
and PBMC samples was similar between treatment groups. By day 3 PI, 100% of 
the PBMC and serum samples obtained from low dose animals were positive for 
PRRSV by virus isolation, whereas 83% and 67% of the PBMC and serum samples 
from high dose group were positive, respectively. On day 5 PI, both the PBMC and 
serum samples collected from all pigs in both treatment groups were positive for 
PRRSV. 
After day 5 PI there were obvious differences in virus isolation results 
between the two treatment groups. Samples collected on days 9 through 19 PI are 
serial samples collected from the same three pigs in each group. PBMC and serum 
samples from high dose pigs were positive for PRRSV on days 9 and 12 PI (table 2). 
However, PRRSV isolation from the PBMC samples of low dose pigs declined over 
the course of these experiments. On day 9 PI, two of the three pigs were positive 
and, by day 19 PI, none of the PBMC samples from low dose pigs were PRRSV-
positive. PRRSV was only detected in the serum of one of three pigs on day 9 PI in 
the low dose group, but on day 12, samples from all three pigs were positive. 
However, vRNA load did not change significantly on day 9 PI (fig.2A); therefore, the 
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virus isolation results may be an artifact of sampling. Nevertheless, by day 19 PI 
serum samples from the low dose pigs were negative for PRRSV by virus isolation 
and at the minimal detection limit for vRNA quantities. 
On day 19 PI none of the PBMC samples from the pigs in the high dose 
group were positive for PRRSV. However, two of the three pigs were positive for 
virus in the sera and vRNA levels in the sera had increased from the day 12 sample 
(table 2 and fig. 2A). On day 20 PI, one of the animals in the high dose group was 
euthanized as a result of respiratory distress. When the two remaining high dose 
animals were sampled at day 26 PI, serum samples from both animals were positive 
for PRRSV (data not shown). On the contrary, the serum samples from the 3 pigs 
remaining in the low dose group were negative for PRRSV. 
Overall, these results, along with vRNA results discussed above, indicate that 
animals exposed to considerably different doses (102 CCID5o versus 106 CCID50) of 
PRRSV cannot be discerned by serum vRNA load during the acute stages of 
infection. However, at some point (between 2 and 3 weeks PI in this study) low dose 
animals clear the virus from the periphery, whilst serum samples from animals 
receiving the high dose remain positive for PRRSV. Interestingly, during the early 
stages of infection PRRSV vRNA titers of animals inoculated with the high dose of 
the virus were not significantly greater than animals receiving the low dose inoculum, 
nor were there significant differences between the numbers of animals in which 
PRRSV was isolated from the serum or PBMC. 
Serum antibody levels were unaffected by the initial dose of PRRSV. The 
antibody response to PRRSV, as measured by HerdCheck® PRRS ELISA 2XR S/P 
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ratios, was unaffected by dose inoculum. Pigs were seronegative on day 0 and pigs 
in both the low and high dose group remained seronegative through day 5. At 9 days 
PI, animals within both groups had seroconverted and had similar S/P ratio averages 
of 1.6 (fig. 2B). The S/P ratios peaked at 12 days PI for both groups, with an 
average S/P ratio of approximately 1.9, and levels declined somewhat over the next 
two weeks. Although not statistically significant, S/P ratios declined to an average of 
1.3 for the high dose group and 1.7 for the low dose group. Overall, this data shows 
that the differences in inoculum dose did not have an affect on the humoral immune 
response, as animals in both groups contained similar levels of PRRSV-specific 
antibody at day 9 PI, the first day any animal was detected as seropositive (fig. 2B). 
Early histological changes in the lung correlate to inoculum dose. In 
order to investigate the effects of viral load on cell infiltration into the lung, sections 
of the cranial and caudal lobes were collected on day 1, 3, and 5 PI from pigs 
infected with a low or high dose of PRRSV for microscopic evaluation. Microscopic 
lesions, when present, were more prevalent in the cranial than the caudal lung 
lobes. Fig. 3 shows changes in cranial lobe histoarchitecture between the two 
treatment groups on days 1, 3, and 5 PI. On day 1 PI, there was no difference in the 
microscopic appearance of the lungs from pigs among the different groups. On day 
3 PI, there was still no difference in the microscopic appearance of the lung from the 
non-infected pigs and the pigs challenged with the low dose of PRRSV. However, 2 
of the 3 pigs challenged with the high dose of PRRSV had microscopic lung lesions 
indicative of interstitial pneumonia consisting of multifocal, mild to moderate 
thickening of the alveolar septa with infiltrates of lymphocytes, plasma cells and 
114 
macrophages. Alveolar lumina contained necrotic cell debris, macrophages and a 
few neutrophils. In addition, one of the pig's lungs had appreciable lymphocytic 
perivascular and peribronchiolar cuffing, and the other had lesions of suppurative 
bronchopneumonia with infiltrates primarily of neutrophils with a few macrophages in 
the airways. By day 5 PI, two of the three pigs challenged with the low dose of 
PRRSV had microscopic lesions of mild to moderate interstitial pneumonia as 
described above, and all three pigs challenged with the high dose of PRRSV had 
moderate lesions of interstitial pneumonia, as well as, lymphocytic perivascular and 
peribronchiolar cuffing and an increase number of neutrophils in the alveolar lumina. 
Type I interferon responses in AM and PBMC of animals infected with a 
low or high dose of PRRSV. In order to investigate the effect of PRRSV dose on 
the type I interferon immune response, mRNA levels of IFN-(3, IFN-a, Mx and PKR 
were measured in PBMC and alveolar macrophages (AM) on days 1, 3, and 5 PI. 
Figure 4B shows that PMBC IFN-(3 and IFN-a mRNA levels did not increase more 
than 3- to 4- fold, respectively, regardless of the inoculum dose. However, there 
were differences between the treatment groups in the transcription of the interferon-
stimulated genes (ISG), Mx and PKR. All of the animals in the high dose group 
showed at least a five-fold increase in Mx mRNA at each time point, whereas only 2 
of the low dose animals reached a five-fold increase on day 3 PI. PKR mRNA levels, 
on average, were greatest in the high dose pigs on day 1 PI, with an average 7-fold 
increase over mock infected animals. A 2.5-fold increase in PKR mRNA was 
detected on day 3, whereas levels on day 1 and day 5 increased less than 2-fold 
(fig. 4B). 
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Similar results were observed for AM, as AM IFN-a and IFN-(B mRNA levels 
did not increase more than 3- to 5- fold, respectively, regardless of inoculum dose 
(fig. 4A). However, there was one animal in each group that had an increase in IFN-
(3 mRNA levels outside of this range. One pig from the high dose group on day 1 and 
one pig from the low dose group on day 5 showed an approximate 10-fold increase 
in IFN-(3 transcription compared to mock infected animals. Aside from single pig in 
the low dose group on day 5, all of the samples from the low dose group showed 
less than a 4-fold increase in IFN-(3 gene transcription in AM on days 1, 3, and 5 PI. 
We observed a gradual increase in IFN-(3 and IFN-a mRNA levels in AM samples 
collected from animals receiving the high dose inoculums, with the greatest increase 
observed at day 5 PI (fig. 4A). 
As IFN-a and IFN-a control the transcription of interferon-stimulated genes, 
such as Mx and PKR, we investigated transcriptional changes of Mx and PKR. 
Although IFN-(B and IFN-a transcription increased over time in AM from the high 
dose group, the downstream genes Mx and PKR did not appear to follow IFN-a or 
IFN-(3 transcription. With the exception of one animal on day 3, Mx and PKR mRNA 
levels in were not elevated beyond 4- and 3- fold level in AM collected from pigs 
receiving the high dose inoculum, respectively. AM from the low dose animals 
displayed similar Mx and PKR transcriptional changes as that observed in AM from 
high dose pigs, with the exception of day 3 PI. Mx and PKR mRNA levels in AM 
collected from the low dose group averaged a 9-fold increase over mock-infected 
animals on day 3 PI. However, as mentioned above, this response was not observed 
at day 5 PI. 
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Serum IFN-y levels correlate with serum viral load, which is independent 
of PRRSV dose. Interferon-gamma (IFN-y) has been shown to inhibit the 
replication of PRRSV in alveolar macrophages (7) and IFN-y mRNA can be detected 
in the lung of PRRSV infected pigs by 1 day PI (11). To determine if IFN-y may be 
differentially produced by animals infected with either a low or high dose of PRRSV, 
IFN-y levels were measured by ELISA from serum samples collected on days 3, 5, 
9, 12, and 19 days PI. Fig. 5 shows that serum IFN-y levels did not differ 
significantly between treatment groups until 19 days PI. At day 19 PI, the IFN-y 
levels in the sera of pigs infected with a low dose of PRRSV began to decline, 
similar to PRRS vRNA load (fig. 2A). However, on day 19 PI, 90 pg/ml IFN-y was 
detected in the sera of animals receiving the high dose of PRRSV, which was 
significantly greater (p<0.05) than serum IFN-y levels receiving the low dose 
inoculum (fig. 5). Overall, serum levels of IFN-y were not significantly different 
between animals inoculated with a low or high dose of virus during the acute stage 
of disease; however, IFN-y levels did correlate with PRRS vRNA load in the sera. As 
low dose pigs became PRRSV-negative, serum IFN-y levels declined; in contrast, as 
high dose pigs were still PRRSV-positive on day 19 PI, sera IFN-y levels were 
elevated (fig. 2A and 5). 
DISCUSSION 
To date this is the first study investigating the effects of the PRRSV dose on 
viral load and the acute interferon response. Surprisingly, there were no significant 
differences in viral load between low and high dose groups measured between day 2 
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and 12 PI. Although type I interferon transcriptional changes were unique to cell type 
(AM or PBMC), results did not indicate an association between type I interferon 
responsiveness and viral dose. However, there was a strong correlation between 
viral load and IFN-y levels in the sera. 
Serum is typically used for diagnosis of PRRSV infection, but relying on viral 
load as a measure of clinical outcome may be misleading. Real-time PGR analysis 
revealed that PRRSV vRNA load was not statistically different between pigs 
inoculated with a low or high dose of virus. However, there were distinct differences 
in the clinical outcome between treatment groups. Two of the three animals in the 
high dose group had to be euthanized (on day 20 and 30 PI, respectively) as a result 
of severe respiratory distress. All animals in the low dose group were PRRSV-
negative (sera) by day 19 PI and remained PRRSV-negative. Using acute stage 
sera vRNA load as a prognostic factor would be extremely misleading, as there was 
no discernable difference among the low and high dose groups between day 2 and 
19 PI. However, as PRRSV cleared from the periphery of animals in the low dose 
group (serum PRRSV-negative), vRNA load increased in serum samples collected 
from the high dose group. Overall, serum viral load may not be a useful marker for 
PRRS disease severity. 
As acute sera vRNA load was similar between pigs receiving a low and high 
dose inoculum, so were blood antibody levels measured by ELISA. It is likely that 
the initial dose of PRRSV an animal is exposed to does not affect the development 
of antigen-specific antibody response. Different PRRSV isolates are genotypically 
unique and consequently, may replicate to different titers in vivo. This, in turn, will 
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likely affect the amount of antibody produced, but not the development of the 
antibody response. For example, it has been demonstrated that cell culture 
attenuated virus does not replicate as well (different viral loads) in vivo as the parent 
strain and although PRRSV-binding antibody levels are lower in pigs infected with 
the attenuated virus, development of antibody is not different (22). Overall, the 
ELISA and viral load data in the current study concurs with the findings of Johnson 
et al. (2004) that the magnitude of the humoral response is related to the level of 
virus replication. The current study also adds that initial inoculum dose does not 
affect development of the antigen-specific antibody response. 
The clinical outcome differences between animals receiving the high and low 
dose inoculum indicate there was an effect elicited by the initial inoculum dose. 
Again, neither sera vRNA load or antibody levels were different between days 2 to 
12 PI; however, sera vRNA loads were drastically different on day 19. In addition, 
the high dose pigs were euthanized as a result of respiratory distress. It has been 
shown that PRRSV persists mainly in lymph nodes and tonsil, but is cleared from the 
blood (24, 41, 42). Lavage and tracheal-bronchial lymph node virus isolation results 
were similar between the low and high dose groups on day 3 and 5 PI (3 out 3 pigs 
positive); however, we did not quantitate tissue viral load at any timepoint. Further 
studies are needed to investigate whether viral load in the tissue is different between 
pigs exposed to a low or high dose inoculum, as this may explain the differential 
clinical outcome between the two groups. 
AM are the primary cell in which PRRSV replicates yet there were minimal 
increases in IFN-(3 or IFN-a gene transcription after PRRSV infection. Type I 
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interferon responses are initiated after recognition double-stranded RNA (dsRNA), 
an intermediate of viral replication. Both toll-like receptor 3 (TLR3) or PKR have 
been shown to induce IFN-(B gene transcription in response to dsRNA recognition 
(28). Once produced, type I interferon induces the production of antiviral mediators, 
such as Mx and PKR (3, 4, 32). A recent study used in situ hybridization to 
investigate IFN-a and Mx mRNA expression in lung sections of PRRSV infected pigs 
and reported changes by day 1 PI (13). The data presented in the current study 
agrees with these findings; however, comparisons to another respiratory virus 
previously shown to induce large quantities in IFN-a/p the lung would be useful. 
Although PRRSV does stimulate transcription of genes involved in the type I 
interferon response, the amount of protein produced may, in fact, be minimal (39). 
The importance of the type I interferon system in combating viral infection is 
highlighted by the numerous mechanisms different viruses have evolved to 
specifically inhibit the IFN-a/p response (5, 40). There is conflicting evidence as to 
whether PRRSV can actively inhibit the production of type I interferon (1, 9, 25, 31) 
and to date, a mechanism in which PRRSV actively inhibits the production of IFN-a 
has not been characterized. Regardless, there is a consensus that IFN-a is 
protective against PRRSV infection, whether supplied as a recombinant protein or 
induced by another viral pathogen (1, 9, 10, 25, 31). It is possible that PRRSV itself 
does not induce a strong type I interferon response in infected cells (9, 25) and 
consequently, there is an overall delay in the activation of the immune response. 
Regardless of whether this is an active or passive event, it allows for early, 
uncontrolled viral replication and subsequent dissemination of the virus. 
120 
It is interesting to note that IFN-y levels in the sera correlated to vRNA load; 
however, there were eventually marked differences between the two groups. As low 
dose pigs cleared virus from the periphery, IFN-y levels decreased; conversely, high 
dose pigs showed a marked increase in both serum IFN-y and vRNA at day 19 PI. It 
has been shown that IFN-y, in addition to IFN-a, can inhibit PRRSV replication (6, 
35), and alveolar macrophages in the lungs of PRRSV infected pigs have been 
shown to produce IFN-y within a week PI (11, 38). The majority of studies examining 
IFN-y response to PRRSV utilize an ELISPOT assay, which identifies the number of 
IFN-y secreting cells after antigen stimulation (14, 29, 36); however, levels of serum 
IFN-y were not examined. IFN-y production by gamma-delta T-cells occurs at 
approximately 2 weeks PI (34), which correlates to the increase in sera IFN-y noted 
here. However, the protective benefits of serum IFN-y during PRRSV infection have 
yet to be determined, as the increase of IFN-y in the high dose pigs did not correlate 
with viral clearance. 
Overall, there are likely several factors governing the activation of the immune 
response to PRRSV during the acute stage of disease. These include, but are not 
limited to, PRRSV isolate genotype and viral dose. Inoculum dose of PRRSV did 
have an affect on cell infiltration into the lung and body temperature, but did not 
differentially induce transcription of genes involved in the type I interferon response. 
Further studies are warranted to investigate the unique changes in IFN-y and viral 
load occurring between day 12 and 19 PI, as pigs challenged with the high dose of 
PRRSV succumbed to respiratory infection and had elevated serum IFN-y levels 
starting at day 19 PI. In addition, detailed studies investigating type I interferon 
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response of alveolar macrophages during PRRSV infection may provide information 
necessary for the rational design of vaccine adjuvants or other therapeutic targets. 
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FIG. 1. Body temperatures of pigs infected with a low (102 CCID50) or high (106 
CCID50) dose of PRRSV (SDSU 73) on days 1 to 5 post infection. Data is 
expressed as the mean ± SEM of at least six pigs per treatment group. 
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FIG.2. Comparison of (A) serum viral RNA (vRNA) load and (B) antibody levels at 
various days post-infection between pigs infected with a low (102 CCID50) or high (106 
CCID50) dose of PRRSV (SDSU 73). Data is expressed as the mean ± SEM for six pigs 
per group on days 1, 2, 3, and 5 or three pigs per group on days 4, 9, 12, 19 and 26 
(only 2 in high dose at day 26). Statistical analysis was performed using a students t-
test and a p-value < 0.05 is noted (*). 
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FIG. 3. Lung histological changes in pig inoculated with a low dose (102 CCID50) or 
high dose (106 CCID50) of PRRSV on days 1, 3, and 5 post-infection. Sections of 
caudal lung lobe were fixed in formalin and subsequently embedded in paraffin, 
sectioned, and stained with hematoxylin and eosin. Original magnification, 16X. 
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FIG. 4. Transcriptional changes in (A) alveolar macrophages or (B) peripheral blood 
mononuclear cells in pigs inoculated with a (A) low dose (102 CCID50) or (o) high 
dose (106 CCIDgo) of PRRSV on days 1, 3, and 5 post-infection. Values are 
expressed as a fold change relative to mock infected animals. 
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FIG. 5. Serum IFN-y levels at various days post-infection in pigs infected with a low 
(102 CCID50) or high (106 CCID50) dose of PRRSV (SDSU 73). Data is expressed as the 
mean ± SEM for six pigs per group on days 3 and 5 or three pigs per group on days 9, 
12, and 19 Statistical analysis was performed using a students t-test and a p-value < 
0.05 is noted (*). Data is expressed as the mean ± SEM 
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TABLE 1: Isolation of viable virus from nasal swabs, bronchial-alveolar lavage, and 
tracheal-bronchial lymph nodes at 1, 3, and 5 days post-infectionb 
SAMPLE SWAB LAVAGE LYMPH NODE 
Dose3 Low High Low High Low High 
Day 1 0/3 2/3 1/3 3/3 1/3 3/3 
Day 3 3/3 3/3 3/3 3/3 3/3 3/3 
Day 5 3/3 3/3 3/3 3/3 3/3 3/3 
aPigs received an intranasal inoculation of either a low (102 CCID50 / ml) or high (106 CCID50 / ml) 
dose of PRRSV, isolate SDSU-73. 
^Numbers represent number of positive animals/total animals tested. 
TABLE 2: Isolation of viable virus from 
peripheral blood mononuclear cells (PBMCs) 
and serum at various days post-infection3. 
SAMPLE PBMCs Serum 
Dose" Low High Low High 
Day 1 1/6 5/6 0/6 6/6 
Day 2 4/6 4/5 4/6 3/6 
Day 3 6/6 4/6 6/6 5/6 
Day 4 2/3 3/3 2/3 3/3 
Day 5 6/6 6/6 6/6 6/6 
Day 9 2/3 3/3 1/3 3/3 
Day 12 1/3 3/3 3/3 3/3 
Day 19 0/3 0/3 0/3 2/3 
"Numbers represent number of positive animals/total animals 
tested 
bPigs received an intranasal inoculation of either a low (102 
CCID50 / ml) or high (10s CCID50 / ml) dose of PRRSV, isolate 
SDSU-73. 
"Pigs euthanized at 30 days post-infection due to respiratory 
distress. 
132 
CHAPTER 5: DISCUSSION 
One main observation that continues to appear throughout this entire 
dissertation is the lack of type I interferon responses elicited to PRRSV. Even more 
importantly, it is antigen-presenting cells (APC) that are not responding to PRRSV 
with production of IFN-a/p. APC are the governing cell of the immune system, as 
APCs bridge innate and adaptive immunity (Iwasaki & Medzhitov, 2004). Viral 
associated glycoproteins or replication intermediates are recognized by APC 
expressed PRR, and the interaction between PAMP and PRR induces type I 
interferon production. Early viral replication is controlled by ISGs, such as Mx and 
PKR. Transitioning from the innate response to adaptive immune response is guided 
by type I interferons, as IFN-a/p induces the expression of molecules associated 
with antigen-presentation, such as MHC class I and CD80/86 (Kawai & Akira, 2006, 
Matsumoto et al., 2004). 
Nevertheless, L-DC nor AM showed enhanced type I interferon responses 
after exposure to PRRSV. IFN-P gene transcription was elevated in both L-DC and 
AM at 12 hours post stimulation, but the response was not sustained to 24 hours. 
MHC class I and CD80/86 expression was either reduced or unchanged in L-DC and 
AM exposed to PRRSV. Reduced expression of MHC class I and CD80/86 was 
likely the result of reduced type I interferon production, as L-DC stimulated with 
PRRSV plus rplFN-a had increased expression of both MHC class I and CD80/86. 
Collectively, studies included in this dissertation with other published work indicate 
suboptimal activation of the type I interferon response during PRRSV infection; 
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consequently, the lack of IFN-a/p production may result in delayed activation of the 
adaptive immune response. 
AM are the primary site of PRRSV replication; therefore, the antiviral 
response elicited by AM after PRRSV infection plays a critical role in controlling virus 
dissemination. Further, soluble factors produced by infected AM are important for 
activating the ensuing immune response. As type I interferon production by AM after 
exposure to PRRSV was minimal, effort was placed on characterizing the innate 
response of AM to dsRNA, a viral intermediate often used for studying antiviral 
immune responses. An investigation into AM responses to dsRNA would provide 
general information on porcine AM antiviral immune responses, information that 
could be used for comparison to antiviral responses elicited to various respiratory 
viruses, including influenza or coronavirus. As opposed to type I interferon measured 
to PRRSV, porcine AM did respond to polylC (synthetic dsRNA) with the production 
of bioactive type I interferon; demonstrating AM can be a source of IFN-a/p during 
viral infection. However, transcription of ISG in AM after polylC were minimal. AM 
pretreated with 2-AP and subsequently stimulated with rpIFN-a did exhibit an 
increase in Mx and PKR transcription, indicating that AM may regulate 
responsiveness to IFN-a/p. Another important finding was polylC enhanced the 
expression of CD80/86 expression on AM, indicating AM may play a role in T-cell 
activation after viral infection. 
It is possible that PRRSV is capable of actively inhibiting activation of the type 
I interferon response. Results generated from investigating AM responses to polylC 
show that AM are capable of producing type I interferon after recognition of dsRNA, 
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a molecule produced during viral infection. However, PRRSV does not induce IFN-
a/p production from infected AM. Taken together, results indicate PRRSV may 
actively inhibit IFN-a/p production. The importance of the type I interferon response 
is made obvious when one considers the numerous mechanisms viruses have for 
developed for inhibiting the IFN-a/p response (Garcia-Sastre, 2002). Some viruses, 
such as influenza, inhibit IFN-a/p synthesis by blocking the recognition of dsRNA by 
host cellular receptors. Other viruses, such hepatitis C and mumps, are able to 
inhibit IFN-a/p signaling by blocking activation of STAT proteins. There are previous 
studies on PRRSV that argue for an IFN-a/p inhibitory mechanism for PRRSV, 
showing PRRSV can inhibit the production of IFN-a/p from cells already infected 
with another virus, such as TGEV (Albina et al., 1998). Nevertheless, other studies 
show that PRRSV does not block IFN-a/p production induced by co-infection with 
another virus, such as TGEV or PCV2 (Buddaert et al., 1998, Chang et al., 2005). 
As PRRSV is an RNA virus, the genome is constantly changing due to the lack of 
proof-reading ability by the polymerase protein. Therefore, immune response elicited 
to PRRSV may be unique and dependent on the isolate of PRRSV used (Lee et al., 
2004). Future efforts in PRRSV research should focus on determining if the PRRSV 
genome encodes for a protein(s) that can inhibit induction of type I interferon in AM. 
Today, PRRSV remains one of the most important economic diseases of 
swine worldwide. Although PRRSV vaccines are available, maximal protection is not 
provided by either licensed vaccine. Thus, either a new, safe and effective vaccine 
needs to be developed or a mechanism for enhancing the protection provided by 
currently available vaccines is urgently needed. Thoroughly identifying mechanisms 
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governing activation of type I interferon antiviral response elicited by cells in the lung 
may provide therapeutic or adjuvant targets. 
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Introduction 
PRRSV is a single-stranded, positive-sense RNA virus in the Arteriviridae family of 
viruses. Viruses of the Arteriviridae family primarily infect cells of the 
monocyte/macrophage lineage and cause a persistent infection in their respective 
host (Plagemann, 1992). PRRSV primarily infects lung macrophages, including 
alveolar and intravascular macrophages (Duan et al., 1998, Thanawongnuwech et 
al., 2000). Peripheral blood monocytes become permissive to PRRSV after 
overnight culture and monocyte-derived macrophages support viral replication 
(Duan et al., 1997). 
The innate antiviral immune response lacks antigen-specificity, but instead 
recognizes conserved pathogen associated molecular patterns (PAMP). The host 
cell is activated after recognition of PAMP by host cell expressed pattern recognition 
receptors (PRR), such as toll-like receptors (TLR). Cytokines and chemokines 
produced by activated AM have an important role in providing early protection 
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against pathogen dissemination and recruiting effector cells to sites of infection. 
Further, AM can serve as antigen-presenting cells (APC), upregulating MHC and 
CD80/86 for activation of naïve T-cells. MO's have recently been described to be as 
efficient at activating CD8+ T-cells as dendritic cells (DC) (Pozzi et al., 2005). 
Double-stranded RNA, intermediates viral genome replication, can be 
recognized by TLR3 or dsRNA dependent protein kinase (PKR) in the host cell. 
Once dsRNA binds to either TLR3 or PKR, differential signaling pathways are 
activated by a series of phosphorylation events, leading to the transcription of type I 
interferons [such as interferon-beta (IFN-J3) and interferon-alpha (IFN-a)]. IFN-(3 and 
IFN-a have potent antiviral activities, and can work in an autocrine/paracrine manner 
to activate infected cells or 'alert' nearby cells to a potential threat. IFN-a/p signals 
for the transcription of several major antiviral effectors, including Mx and PKR 
(Asano et al., 2002, Asano et al., 2004, Muller et al., 1992). In addition, type I 
interferon can induce an upregulation in the expression of major histocompatability 
complex (MHC) class I. 
Mx proteins are a family of GTPases that are thought to interfere with viral 
replication and assembly (Kochs et al., 2005). It has been shown that Mx protein 
interacts with viral ribonucleoprotein complexes and prevents their transport into the 
nucleus (Haller & Kochs, 2002). In addition, Mx in the nucleus of host cells was 
shown to hinder viral polymerase activity (Pavlovic et al., 1993). PKR is a 
serine/threonine kinase constitutive^ expressed in the cytoplasm of the host cell, but 
can also be upregulated in an interferon-dependent manner. Upon binding to 
dsRNA, PKR is activated and able to hinder viral mRNA translation by 
138 
phosphorylating the alpha subunit of the eukaryotic initiation factor 2 (elF-2a), which 
renders elF-2a incapable of initiating protein synthesis. In addition, PKR activates a 
member of the NFKB transcription factor family via activation of IKB kinase, which 
triggers type I interferon production (Chu et al., 1999, Kumar et al., 1994). Therefore, 
PKR is not only involved in the response to type I interferon, but can induce the 
production of type I interferon as well (Balachandran et al., 2000, Bonnet et al., 
2000, Der&Lau, 1995). 
Type I interferon levels the lungs of PRRSV infected pigs is fairly modest 
when compared to animals infected with swine influenza virus (SIV). The level of 
IFN-a in the BAL is approximately 1,000 to 10,000-fold less in PRRSV infected pigs 
than swine influenza virus (SIV) infected pigs, with less than 1000 U/ml detected 
(Van Reeth et al., 1999). Although SIV infection results in an acute, somewhat 
severe clinical disease, pigs typically clear the virus within a week. This indicates 
that while the immune response during SIV infection may induce pathology, it does 
result in clearance (Van Reeth et al., 2002). On the other hand, PRRSV elicits a 
modest immune response (Murtaugh et al., 2002), and can persist in an animal for 
several months (Wills et al., 2003) 
IFN-a has been shown to inhibit PRRSV replication, both in vitro (Albina et al., 
1998) and in vivo (Buddaert et al., 1998, Chang et al., 2005). However, little IFN-a is 
produced during PRRSV infection (Albina et al., 1998, Buddaert et al., 1998, Van 
Reeth et al., 1999), which is consistent with the observed delay in the adaptive 
immune response to PRRSV (Murtaugh et al., 2002). It has been shown that IFN-a 
produced in response to another virus, such as porcine circovirus 2 (PCV2) or 
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porcine respiratory coronavirus (PRCV), is protective against PRRSV infection 
(Buddaert et al., 1998, Chang et al., 2002). Overall, these data indicate the lack of 
IFN-a produced in response to PRRSV is significant. 
In the current study, AM were used to investigate type I interferon production 
in response to PRRSV. Thus, transcription of IFN-(3, IFN-a, and interferon-stimulated 
genes (ISG), Mx and PKR, was examined after PRRSV exposure. In addition, 
changes in MHC class I and CD80/86 expression were investigated to determine if 
PRRSV could alter expression of molecules involved with antigen-presentation. We 
show that transcription of type I interferon is elevated at 12 hours post stimulation, 
but returned to baseline by 24 hours. Expression of MHC class I or CD80/86 did not 
change significantly from non-stimulated cells. However, AM stimulated with polylC 
showed a slight increase in MHC class I and significant increase in CD80/86 
expression, indicating molecules associated with antigen-presentation are stimulated 
by dsRNA, an intermediate of viral replication. 
Materials and Methods 
Animals 
Conventionally reared, 3 to 6 week old, mixed sex pigs were maintained in isolation 
rooms at the National Animal Disease Center, Ames, IA according to facility animal 
care and use guidelines. Animals received 1 ml per day for three days of ceftiofur 
(Excenel; 50mg/mi) intramuscularly, with the first dose given the day pigs were 
transported to the facility. Pigs were anesthetized with a combination of ketamine 
and xylazine given intramuscularly and subsequently euthanized with an overdose of 
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pentobarbital given intravenously. Three to six animals per experiment were used 
and the number of replicates is noted in each figure. 
Macrophage isolation and culture 
Lungs were lavaged with 300 ml of PBS and approximately 200 ml was recovered. 
Collected lavage was centrifuged at 400 x g for 15 minutes, cells washed once with 
PBS, and resuspended in supplemented media [RPMI 1640, 5% swine sera, 5 mM 
HEPES, 1 mM L-glutamine,1X antibiotic-antimycotic, and 50 pg/ml gentamicin 
(Invitrogen Life Technologies, Carlsbad, CA). Cells were cultured in 150 x 15 mm 
Petri dishes for 2 h at 37°C. Non-adherent cells were removed and adherent 
macrophages released with a cell scraper, collected, washed once, and counted on 
a hemacytometer. Macrophages were seeded at 3.5 x 105 cells per well in a 48-well 
flat bottom plate with a final volume of 500 pi for cytokine studies (RT-PCR ) or at 1 x 
105 cells per well in a 96-well plate with a final volume of 200 pi for phenotype 
studies. Macrophages were stimulated for the indicated times with 50 pg/ml 
polyriboinosinic:polyribocytidylic acid (polylC; Amersham Biosciences, Piscataway, 
NJ) or NADC-8 isolate of PRRSV at MOI=1. Non-stimulated cells were included at 
each timepoint as controls. 
RNA preparation and real-time RT-PCR 
At each indicated timepoint, supernatant discarded. Macrophages were lysed on the 
culture plate with RLT buffer, first step for RNA isolation (RNeasy Mini Isolation Kit, 
Qiagen). RNA was isolated, DNAse treated (RNase-free DNase, Qiagen), and cDNA 
141 
was synthesized using random hexamers according to manufacturers 
recommendations (Invitrogen Life Technologies, Carlsbad, CA). Sybr green based 
real-time PCR was carried out for various mRNA targets according to manufacturer's 
recommendations (SYBR green Master Mix, Applied Biosystems). Briefly, SYBR 
green master mix, primers, and template were mixed in a 20 pi reaction and cycled 
as follows: 95 °C for 15 minutes; 95 °C for 15 seconds followed by 50 °C for 1 minute 
(45 cycles) and final dissociation step. All samples were run in duplicate. Levels of 
mRNA were calculated using the 2"MCt method, which expresses mRNA in treated 
cells relative to non-stimulated cells after normalizing to (3-actin (Livak and 
Schmittgen, 2001). Primers were generated using Primer Express, purchases from 
Integrated DNA Technologies (IDT; Coralville, IA) and used at a final concentration 
of 600 nM. Primer pair efficiency was confirmed using the method described by 
Livak and Schmittgen, 2001. PCR products were less than 100 base pairs in size 
and primers were as follows (5' to 3'): (3-actin-forward CTCCTTCCTGGGCATGGA, |3-
actin-reverse CGCACTTCATGATCGAGTTGA; IFN-(B-forward TGCAACCACCACAATTCC, 
IFN-p-reverse CT G AG AAT GCCG AAG AT CTG ; IFN-a-forward 
GCCTCCTGCACCAGTTCTACA, IFN-a-reverse TGCATGACACAGGCTTCCA; Mx-1-forward 
TAGGCAATCAGCCATACG, Mx-1-reverse GTTGATGGTCTCCTGCTTAC; PKR-forward 
GAGAAGGTAGAGCGTGAAG, PKR-reverse CCAGCAACCGTAGTAGAG: RANTES-forward 
CTGCTTTGCCTACCTCTC, RANTES-reverse CTTGCTGCTGGTGTAGAA; TNF-a-forward 
ccACGTTGTAGCCAATGTc, TNF-oreverse CTGGGAGTAGATGAGGTACAG. Primers were 
generated using Primer Express, purchased from Integrated DNA Technologies 
142 
(IDT, Coralville, IA), and primer pair efficiency confirmed using the method described 
by Livak and Schmittgen, 2001. 
Phenotyping 
At 18 hours post stimulation, AM were phenotyped using flow cytometry. Cell 
staining was carried out as previously described (Paillot et al., 2001). Anti-MHC 
class I (PT85A) was purchased from VMRD, CD80/86 expression was determined 
using hCTLA4-mouse immunoglobulin fusion protein (Ancell). Data was acquired 
using CellQuest Pro software (BD Biosciences) on a LSR flow cytometer (Becton 
Dickinson) and analyzed using FlowJo software (TreeStar). 
Results 
Type I interferon response to PRRSV 
Type I interferon production is induced in the host cell after recognition of dsRNA in 
the host cell. To investigate the induction of IFN-P and IFN-a in AM after PRRSV 
infection, real-time PCR was used to measure transcript levels 12 and 24 hours after 
stimulation. Figure 1 shows AM responded to PRRSV with increased transcription of 
IFN-p. At 12 hours there was an average 18-fold increase in IFN-P mRNA levels in 
PRRSV treated AM compared to mock itreated cells. By 24 hours post infection, 
IFN-P mRNA levels had decreased to about 2.5 fold increase. IFN-a mRNA levels 
were increased about 2.5 fold at 12 hours, but had returned to baseline by 24 hours 
post stimulation. These results indicated that PRRSV does induce transcription of 
type I interferon genes, IFN-P and IFN-a, early after infection. 
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Once produced, IFN-a/p induces the transcription of several antiviral 
mediators, including PKR and Mx. To determine if increases of IFN-P or IFN-a 
measured at 12 and 24 hours after PRRSV exposure resulted in the upregulation of 
interferon-stimulated genes, Mx and PKR levels were measured. Figure 1 shows an 
approximate 2-fold increase in Mx and PKR mRNA levels 12 hours after PRRSV 
infection, but these levels returned to baseline by 24 hours. Taken together, these 
results show minimal activation of the type I interferon system after PRRSV infection 
in AM. 
MHC class I and CD80/86 expression 
In addition to inducing activation of the type I interferon system, recognition of 
dsRNA can result in the increased expression of molecules associated with antigen 
presentation, such as MHC class I or CD80/86. As the early adaptive immune 
response to PRRSV has been characterized as weak, resulting in delayed 
elimination of virus from the host (Murtaugh et al., 2002) we sought to determine if 
PRRSV altered the expression of MHC class I or CD80/86 on AM. Figure 2 shows 
that MHC class I and CD80/86 expression did not differ significantly in response to 
PRRSV. Interestingly, AM stimulated with polylC, a synthetic dsRNA molecule, 
showed a significant increase in CD80/86 expression over PRRSV infected AM. 
Overall, these data indicate that AM can respond to viral infection with enhanced 
expression of molecules involved in antigen presentation, but do not upregulate 
MHC class I or CD80/86 after PRRSV infection. 
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Figure 1: Transcriptional changes of type I interferon genes in alveolar macrophages 
(AM) stimulated with PRRSV. AM isolated from healthy pigs were stimulated with 
PRRSV (MOI=1) for 12 or 24 hours. Quantitative real-time PGR was used to measure 
mRNA levels of IFN-p, IFN-a, Mx, and PKR. Data is expressed as the mean ± SEM 
fold increase in gene expression relative to mock infected cells. Data is a 
representative experiment out of three. 
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Figure 2: Phenotypic changes in alveolar macrophages (AM) after polylC or PRRSV 
stimulation. AM isolated from healthy pigs were stimulated with polylC (50 pg/ml) or 
PRRSV (MOI=1) for 18 hours and expression of MHC-I and CD80/86 measured by 
flow cytometry. Values represent percentage mean fluorescence intensity relative to 
sham treated cells (100%, dotted line). Data is shown as mean ± SEM of four animals 
and is representative of two individual experiments. 
